1
|
Oh SJ, King P. Sensory Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Neglected Immunotherapy-Responsive Sensory Neuropathy. J Clin Neurol 2024; 20:276-284. [PMID: 38330421 PMCID: PMC11076188 DOI: 10.3988/jcn.2023.0469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2023] [Revised: 12/12/2023] [Accepted: 12/14/2023] [Indexed: 02/10/2024] Open
Abstract
BACKGROUND AND PURPOSE To report an improvement with immunotherapy in 34 (85%)/40 patients who required an immunotherapy among 56 patients with sensory chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). METHODS Sensory CIDP was diagnosed when two inclusion criteria are met: 1) acquired, chronic progressive or relapsing symmetrical or asymmetrical sensory polyneuropathy that had progressed for >2 months; and 2) definite electrophysiological and/or biopsy evidence of demyelinating neuropathy. RESULTS Fifty-six patients with sensory CIDP were identified. Evidence of demyelination was obtained from by the routine motor nerve conduction study (NCS) in 39 (70%) patients, from a nerve biopsy in 10, and from a near-nerve needle sensory NCS in 7 patients. The most prominent laboratory abnormality was a high protein level in the cerebrospinal fluid in 21 (49%) of 43 tested patients. Immunotherapy was required in 41 (79%) of the 52 followed-up patients. An improvement with immunotherapy was observed in 36 (88%)/41 patients. In three patients, motor weakness developed in 5-8 years' follow-up period and so, their diagnosis was changed to CIDP. CONCLUSIONS Sensory CIDP is responded to an immunotherapy in 88% of the treated patients. Sensory CIDP was diagnosed by the routine motor NCS in 70% of patients and by a sural nerve biopsy in 18% of patients. Thus, sensory CIDP should be recognized as a treatable CIDP variant among the different types of "idiopathic sensory neuropathy."
Collapse
Affiliation(s)
- Shin J Oh
- Department of Neurology, University of Alabama at Birmingham, Veterans Affairs Medical Center, Birmingham, AL, USA.
| | - Peter King
- Department of Neurology, University of Alabama at Birmingham, Veterans Affairs Medical Center, Birmingham, AL, USA
| |
Collapse
|
2
|
Hubbard T, Liu X, Sulieman M, Drew P, Brown I, English R, Abbas I, Potiszil K, Barta M, Jackson N, King P. Evaluating a novel patient pathway to manage symptomatic breast referrals (the blue flag clinic): a longitudinal observational study. Ann R Coll Surg Engl 2023. [PMID: 37489547 DOI: 10.1308/rcsann.2023.0028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/26/2023] Open
Abstract
INTRODUCTION A novel referral pathway for exhibited breast symptom (EBS) referrals to manage increasing referrals of urgent suspected cancer (USC) was implemented in our trust. We report on the safety and effect on compliance with the 2-week-wait rule (2WW). METHODS A single-centre longitudinal observational study included all patients referred to a UK breast unit during 13 May 2019 to 27 March 2020 (period 1) and 8 February 2021 to 31 January 2022 (period 2). USC referrals were assessed in a one-stop clinic (red flag clinic [RFC]); EBS referrals were assessed in a new clinic in which clinical evaluation was performed and imaging occurred subsequently (blue flag clinic [BFC]). Patients were followed up to determine the symptomatic interval cancer rate. RESULTS There were 9,695 referrals; 1,655 referrals (17%) were assessed in the BFC after 63 exclusions. Some 95.9% of patients had a benign clinical examination (P1/P2), 80.1% had imaging (mammogram or ultrasound) and 4% had a tissue biopsy. In total, 16/1,655 (0.97%) BFC patients and 510/7,977 (8.2%) RFC patients were diagnosed with breast cancer (breast cancer detection rate). Some 1,631 patients (with 1,639 referrals) were discharged and followed up for a median of 17 months (interquartile range 12-32) with one subsequent cancer diagnosis (symptomatic interval cancer rate, 0.06%). Implementation of the BFC pathway increased 3-month average trust performance of USC referrals with 2WW standard from 8.5% to 98.7% (period 1) and from 30% to 66% (period 2). CONCLUSIONS The BFC pathway for EBS patients is safe and implementation led to improvement against the 2WW target for USC referrals, ensuring resources are prioritised to patients with the highest likelihood of breast cancer.
Collapse
Affiliation(s)
- Tje Hubbard
- Royal Cornwall Hospitals NHS Trust, UK
- University of Exeter, UK
| | - X Liu
- Royal Cornwall Hospitals NHS Trust, UK
| | | | - P Drew
- Royal Cornwall Hospitals NHS Trust, UK
| | - I Brown
- Royal Cornwall Hospitals NHS Trust, UK
| | - R English
- Royal Cornwall Hospitals NHS Trust, UK
| | - I Abbas
- Royal Cornwall Hospitals NHS Trust, UK
| | | | - M Barta
- Royal Cornwall Hospitals NHS Trust, UK
| | - N Jackson
- Royal Cornwall Hospitals NHS Trust, UK
| | - P King
- Royal Cornwall Hospitals NHS Trust, UK
| |
Collapse
|
3
|
Duran B, Meziani ZE, Joosten S, Jones MK, Prasad S, Peng C, Armstrong W, Atac H, Chudakov E, Bhatt H, Bhetuwal D, Boer M, Camsonne A, Chen JP, Dalton MM, Deokar N, Diefenthaler M, Dunne J, El Fassi L, Fuchey E, Gao H, Gaskell D, Hansen O, Hauenstein F, Higinbotham D, Jia S, Karki A, Keppel C, King P, Ko HS, Li X, Li R, Mack D, Malace S, McCaughan M, McClellan RE, Michaels R, Meekins D, Paolone M, Pentchev L, Pooser E, Puckett A, Radloff R, Rehfuss M, Reimer PE, Riordan S, Sawatzky B, Smith A, Sparveris N, Szumila-Vance H, Wood S, Xie J, Ye Z, Yero C, Zhao Z. Determining the gluonic gravitational form factors of the proton. Nature 2023; 615:813-816. [PMID: 36991189 DOI: 10.1038/s41586-023-05730-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2022] [Accepted: 01/13/2023] [Indexed: 03/31/2023]
Abstract
The proton is one of the main building blocks of all visible matter in the Universe1. Among its intrinsic properties are its electric charge, mass and spin2. These properties emerge from the complex dynamics of its fundamental constituents-quarks and gluons-described by the theory of quantum chromodynamics3-5. The electric charge and spin of protons, which are shared among the quarks, have been investigated previously using electron scattering2. An example is the highly precise measurement of the electric charge radius of the proton6. By contrast, little is known about the inner mass density of the proton, which is dominated by the energy carried by gluons. Gluons are hard to access using electron scattering because they do not carry an electromagnetic charge. Here we investigated the gravitational density of gluons using a small colour dipole, through the threshold photoproduction of the J/ψ particle. We determined the gluonic gravitational form factors of the proton7,8 from our measurement. We used a variety of models9-11 and determined, in all cases, a mass radius that is notably smaller than the electric charge radius. In some, but not all cases, depending on the model, the determined radius agrees well with first-principle predictions from lattice quantum chromodynamics12. This work paves the way for a deeper understanding of the salient role of gluons in providing gravitational mass to visible matter.
Collapse
Affiliation(s)
- B Duran
- Physics Division, Argonne National Laboratory, Lemont, IL, USA
- Department of Physics, Temple University, Philadelphia, PA, USA
| | - Z-E Meziani
- Physics Division, Argonne National Laboratory, Lemont, IL, USA.
- Department of Physics, Temple University, Philadelphia, PA, USA.
| | - S Joosten
- Physics Division, Argonne National Laboratory, Lemont, IL, USA
| | - M K Jones
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - S Prasad
- Physics Division, Argonne National Laboratory, Lemont, IL, USA
| | - C Peng
- Physics Division, Argonne National Laboratory, Lemont, IL, USA
| | - W Armstrong
- Physics Division, Argonne National Laboratory, Lemont, IL, USA
| | - H Atac
- Department of Physics, Temple University, Philadelphia, PA, USA
| | - E Chudakov
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - H Bhatt
- Department of Physics & Astronomy, Mississippi State University, Mississippi State, MS, USA
| | - D Bhetuwal
- Department of Physics & Astronomy, Mississippi State University, Mississippi State, MS, USA
| | - M Boer
- Department of Physics, Virginia Polytechnic Institute & State University, Blacksburg, VA, USA
| | - A Camsonne
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - J-P Chen
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - M M Dalton
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - N Deokar
- Department of Physics, Temple University, Philadelphia, PA, USA
| | - M Diefenthaler
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - J Dunne
- Department of Physics & Astronomy, Mississippi State University, Mississippi State, MS, USA
| | - L El Fassi
- Department of Physics & Astronomy, Mississippi State University, Mississippi State, MS, USA
| | - E Fuchey
- Department of Physics, University of Connecticut, Storrs, CT, USA
| | - H Gao
- Department of Physics, Duke University, Durham, NC, USA
| | - D Gaskell
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - O Hansen
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - F Hauenstein
- Department of Physics, Old Dominion University, Norfolk, VA, USA
| | - D Higinbotham
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - S Jia
- Department of Physics, Temple University, Philadelphia, PA, USA
| | - A Karki
- Department of Physics & Astronomy, Mississippi State University, Mississippi State, MS, USA
| | - C Keppel
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - P King
- Department of Physics and Astronomy, Ohio University, Athens, OH, USA
| | - H S Ko
- CNRS/IN2P3, IJCLab Orsay, Université Paris-Saclay, Gif-sur-Yvette, France
| | - X Li
- Department of Physics, Duke University, Durham, NC, USA
| | - R Li
- Department of Physics, Temple University, Philadelphia, PA, USA
| | - D Mack
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - S Malace
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - M McCaughan
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - R E McClellan
- Natural Sciences Department, Pensacola State College, Pensacola, FL, USA
| | - R Michaels
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - D Meekins
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - Michael Paolone
- Department of Physics, Temple University, Philadelphia, PA, USA
| | - L Pentchev
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - E Pooser
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - A Puckett
- Department of Physics, University of Connecticut, Storrs, CT, USA
| | - R Radloff
- Department of Physics and Astronomy, Ohio University, Athens, OH, USA
| | - M Rehfuss
- Department of Physics, Temple University, Philadelphia, PA, USA
| | - P E Reimer
- Physics Division, Argonne National Laboratory, Lemont, IL, USA
| | - S Riordan
- Physics Division, Argonne National Laboratory, Lemont, IL, USA
| | - B Sawatzky
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - A Smith
- Department of Physics, Duke University, Durham, NC, USA
| | - N Sparveris
- Department of Physics, Temple University, Philadelphia, PA, USA
| | - H Szumila-Vance
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - S Wood
- Experimental Nuclear Physics Division, Thomas Jefferson National Accelerator Facility, Newport News, VA, USA
| | - J Xie
- Physics Division, Argonne National Laboratory, Lemont, IL, USA
| | - Z Ye
- Physics Division, Argonne National Laboratory, Lemont, IL, USA
| | - C Yero
- Department of Physics, Old Dominion University, Norfolk, VA, USA
| | - Z Zhao
- Department of Physics, Duke University, Durham, NC, USA
| |
Collapse
|
4
|
Ross AJ, Sherriff A, Kidd J, Deas L, Eaves J, Blokland A, Wright B, King P, McMahon AD, Conway DI, Macpherson LMD. Evaluating childsmile, Scotland's National Oral Health Improvement Programme for children. Community Dent Oral Epidemiol 2023; 51:133-138. [PMID: 36753390 DOI: 10.1111/cdoe.12790] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2021] [Revised: 06/08/2022] [Accepted: 08/15/2022] [Indexed: 02/09/2023]
Abstract
In the early 2000s, a Scottish Government Oral Health Action Plan identified the need for a national programme to improve child oral health and reduce inequalities. 'Childsmile' aimed to improve child oral health in Scotland, reduce inequalities in outcomes and access to dental services, and to shift the balance of care from treatment to prevention through targeted and universal components in dental practice, community and educational settings. This paper describes how an embedded, theory-based research and evaluation arm with multi-disciplinary input helps determine priorities and provides important strategic direction. Programme theory is articulated in dedicated, dynamic logic models, and evaluation themes are as follows: population-level data linkage; trials and economic evaluations; investigations drawing from behavioural and implementation science; evidence reviews and updates; and applications of systems science. There is also a growing knowledge sharing network internationally. Collaborative working from all stakeholders is necessary to maintain gains and to address areas that may not be working as well, and never more so with the major disruptions to the programme from the COVID-19 pandemic and response. Conclusions are that evaluation and research are synergistic with a complex, dynamic programme like Childsmile. The evidence obtained allows for appraisal of the relative strengths of component interventions and the reach and impact of Childsmile to feed into national policy.
Collapse
Affiliation(s)
- Alastair J Ross
- Community Oral Health Group, University of Glasgow Dental School, School of Medicine, Dentistry & Nursing, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK
| | - Andrea Sherriff
- Community Oral Health Group, University of Glasgow Dental School, School of Medicine, Dentistry & Nursing, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK
| | - Jamie Kidd
- Community Oral Health Group, University of Glasgow Dental School, School of Medicine, Dentistry & Nursing, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK
| | - Leigh Deas
- Public Dental Service, NHS Lanarkshire, Glasgow, UK
| | - Jenny Eaves
- Public Dental Service, NHS Lanarkshire, Glasgow, UK
| | - Alex Blokland
- Department of Epidemiology and Public Health, University College London, London, UK
| | - Bill Wright
- Community Oral Health Group, University of Glasgow Dental School, School of Medicine, Dentistry & Nursing, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK
| | - Peter King
- Public Dental Service, NHS Lanarkshire, Glasgow, UK
| | - Alex D McMahon
- Community Oral Health Group, University of Glasgow Dental School, School of Medicine, Dentistry & Nursing, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK
| | - David I Conway
- Community Oral Health Group, University of Glasgow Dental School, School of Medicine, Dentistry & Nursing, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK
| | - Lorna M D Macpherson
- Community Oral Health Group, University of Glasgow Dental School, School of Medicine, Dentistry & Nursing, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK
| |
Collapse
|
5
|
Lakeman R, Hurley J, Campbell K, Hererra C, Leggett A, Tranter R, King P. High fidelity dialectical behaviour therapy online: Learning from experienced practitioners. Int J Ment Health Nurs 2022; 31:1405-1416. [PMID: 35789190 PMCID: PMC9795868 DOI: 10.1111/inm.13039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/18/2022] [Indexed: 12/30/2022]
Abstract
Dialectical behaviour therapy (DBT) is an effective treatment for borderline personality disorder and other problems underpinned by difficulties with emotional regulation. The main components of DBT are skills training groups and individual therapy. The COVID-19 outbreak forced a rapid adaptation to online delivery, which largely mirrored face-to-face programmes using videoconferencing technology. This study aimed to elicit and describe the experiences and learning of therapists involved in providing high-fidelity DBT programmes via the Australian DBT Institute, which established an online delivery platform called DBT Assist™ prior to the COVID-19 pandemic. The report conforms with the consolidated criteria for reporting qualitative research (COREQ). Seven therapists were interviewed. Data were transcribed and analysed thematically. Delivering skills training online, either exclusively or in hybrid form (with face-to-face individual therapy), was acceptable and even preferable to therapists and clients. It was considered safe, the programme was associated with few non-completers, and it improved the accessibility of DBT to those who might otherwise not be able to engage in a face-to-face programme. Skills training utilized a 'flipped-learning' approach which improved the efficiency of online delivery. Other unique and helpful features of the online programme were described. The best outcomes associated with online DBT are likely to be achieved through careful adaptation to the online environment in accord with the principles of DBT rather than mirroring face-to-face processes. Further research is required to determine the efficacy of online therapy relative to face-to-face, and who might be best suited to different modes of delivery.
Collapse
Affiliation(s)
- Richard Lakeman
- Faculty of Health, Southern Cross University, Bilinga, Queensland, Australia
| | - John Hurley
- Faculty of Health, Southern Cross University, Bilinga, Queensland, Australia
| | - Katrina Campbell
- Faculty of Health, Southern Cross University, Bilinga, Queensland, Australia
| | | | - Andrew Leggett
- Mid North Coast Local Health District, Port Macquarie, New South Wales, Australia
| | - Richard Tranter
- Mid North Coast Local Health District, Port Macquarie, New South Wales, Australia
| | - Peter King
- Faculty of Health, Southern Cross University, Bilinga, Queensland, Australia
| |
Collapse
|
6
|
Lakeman R, King P, Hurley J, Tranter R, Leggett A, Campbell K, Herrera C. Towards online delivery of Dialectical Behaviour Therapy: A scoping review. Int J Ment Health Nurs 2022; 31:843-856. [PMID: 35048482 PMCID: PMC9305106 DOI: 10.1111/inm.12976] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/26/2021] [Revised: 12/24/2021] [Accepted: 01/03/2022] [Indexed: 12/31/2022]
Abstract
Dialectical Behaviour Therapy (DBT) programmes are often the only available treatment for people diagnosed with borderline personality disorder and were rapidly converted to online delivery during the COVID-19 pandemic. Limited research exists surrounding how the major elements of DBT are delivered in an online environment. This scoping review considered the operationalization of online delivery of DBT and its effectiveness. EBSCO host databases were searched using free text. Of 127 papers, 11 studies from 2010 to 2021 investigating online DBT for any clinical population were included in the review. A narrative synthesis of papers selected was undertaken. Seven articles reported results from five clinical trials (n = 437). Most adaptations mirrored face-to-face programmes although there was considerable variation in how therapy was facilitated. Attendance was reported to be greater online with comparable clinical improvements to face-to-face for those who remained in therapy. Additional challenges included managing risk, therapist preparedness and technology difficulties. Online delivery of DBT programmes is feasible and may be more accessible, acceptable and as safe and effective as face-to-face delivery. However, mirroring face to face delivery in an online environment may not be the most effective and efficient way to adapt DBT to online provision. Research is needed to identify areas which require further adaptation.
Collapse
Affiliation(s)
- Richard Lakeman
- Faculty of Health, Southern Cross University, Bilinga, Queensland, Australia
| | - Peter King
- Australian DBT Institute, Southport, Queensland, Australia
| | - John Hurley
- Faculty of Health, Southern Cross University, Bilinga, Queensland, Australia
| | - Richard Tranter
- Mid North Coast Local Health District, Port Macquarie Base Hospital, Port Macquarie, New South Wales, Australia
| | - Andrew Leggett
- Mid North Coast Local Health District, Port Macquarie Base Hospital, Port Macquarie, New South Wales, Australia
| | - Katrina Campbell
- Faculty of Health, Southern Cross University, Bilinga, Queensland, Australia
| | | |
Collapse
|
7
|
Tüchler M, Sirghi F, Bazzi M, Bosnar D, Bragadireanu M, Carminati M, Cargnelli M, Clozza A, Curceanu C, Deda G, Del Grande R, De Paolis L, Fiorini C, Guaraldo C, Iliescu M, Iwasaki M, King P, Levi Sandri P, Marton J, Miliucci M, Moskal P, Napolitano F, Niedzwiecki S, Piscicchia K, Scordo A, Sgaramella F, Shi H, Silarski M, Sirghi D, Skurzok M, Spallone A, Vazquez Doce O, Widmann E, Zmeskal J. Main Features of the SIDDHARTA-2 Apparatus for Kaonic Deuterium X-Ray Measurements. EPJ Web Conf 2022. [DOI: 10.1051/epjconf/202226201016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The low-energy, non-perturbative regime of QCD can be studied directly by X-ray spectroscopy of light kaonic atoms. The SIDDHARTA-2 experiment, located at the DAΦNE collider, aims to measure the 2p → 1s transition in kaonic deuterium for the first time to extract the antikaon-nucleon scattering lengths. This measurement is impeded, inter alia, by the low K−d X-ray yield. Hence, several updates have been implemented on the apparatus to increase the signal-to-background ratio, which are discussed in detail in this paper: a lightweight gas target cell, novel Silicon Drift Detectors for the X-ray detection with excellent performance, and a veto system for active background suppression. The experiment has undergone a first preparatory run during DAΦNE’s commissioning phase in 2021, concluding with a successful kaonic helium measurement.
Collapse
|
8
|
De Paolis L, Bazzi M, Bosnar D, Bragadireanu M, Cargnelli M, Carminati M, Clozza A, Deda G, Del Grande R, Fabbietti L, Fiorini C, Friščić I, Guaraldo C, Iliescu M, Iwasaki M, Khreptak A, King P, Sandri PL, Manti S, Marton J, Miliucci M, Moskal P, Napolitano F, Niedźwiecki S, Ohnishi H, Piscicchia K, Sada Y, Scordo A, Sgaramella F, Shi H, Silarski M, Sirghi D, Sirghi F, Skurzok M, Spallone A, Toho K, Tüchler M, Doce OV, Yoshida C, Zmeskal J, Curceanu C. Trigger rejection factor in the first kaonic helium run with the complete SIDDHARTA-2 setup. EPJ Web Conf 2022. [DOI: 10.1051/epjconf/202227000028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
The SIDDHARTA-2 experiment aims to perform the first measurement of the kaonic deuterium 2p → 1s x-ray transition energy. Such measurement, together with the measurement of kaonic hydrogen 2p → 1s x-ray energy transition performed by the SIDDHARTA experiment in 2011, allows the determination of kaon proton and kaon neutron scattering lengths and represents a fundamental input for the low energies QCD in the strangeness sector theory. The SIDDHARTA-2 experiment is presently installed at the DAΦNE electronpositron collider at the National Laboratories of Frascati, in Italy. In May 2022, the kaonic 4He x-ray transitions measurement was performed by the complete SIDDHARTA-2 setup, by using a gaseous target. The result of this measurement is presented in this paper, with a specific focus on the background rejection performed by the kaon trigger system.
Collapse
|
9
|
Tosca EM, Terranova N, Stuyckens K, Dosne AG, Perera T, Vialard J, King P, Verhulst T, Perez-Ruixo JJ, Magni P, Poggesi I. A translational model-based approach to inform the choice of the dose in phase 1 oncology trials: the case study of erdafitinib. Cancer Chemother Pharmacol 2022; 89:117-128. [PMID: 34786600 DOI: 10.1007/s00280-021-04370-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Accepted: 10/22/2021] [Indexed: 10/19/2022]
Abstract
PURPOSE Erdafitinib (JNJ-42756493, BALVERSA) is a tyrosine kinase inhibitor indicated for the treatment of advanced urothelial carcinoma. In this work, a translational model-based approach to inform the choice of the doses in phase 1 trials is illustrated. METHODS A pharmacokinetic (PK) model was developed to describe the time course of erdafitinib plasma concentrations in mice and rats. Data from multiple xenograft studies in mice and rats were analyzed using the Simeoni tumor growth inhibition (TGI) model. The model parameters were used to derive a range of erdafitinib exposures that might inform the choice of the doses in oncology phase 1 trials. Conversion of exposures to doses was based on preliminary PK assessments from the first-in human (FIH) study. RESULTS A one-compartment PK disposition model, with linear absorption and dose-dependent clearance, adequately described the PK data in both mice and rats via an allometric scaling approach. The TGI model was able to describe tumor growth dynamics, providing quantitative measurements of erdafitinib antitumor potency in mice and rats. Based on these estimates, ranges of efficacious unbound concentration were identified for erdafitinib in mice (0.642-5.364 μg/L) and rats (0.782-2.565 μg/L). Based on the FIH data, it was possible to transpose exposures into doses and doses of above 4 mg/day provided erdafitinib exposures associated with significant TGI in animals. The findings were in agreement with the results of the FIH trial, in which the first hints of clinical activities were observed at 6 mg. CONCLUSION The successful modeling exercise of erdafitinib preclinical data showed how translational PK-PD modeling might be a tool to help to inform the choice of the doses in FIH studies.
Collapse
Affiliation(s)
- E M Tosca
- Dipartimento di Ingegneria Industriale e dell'informazione, Università degli Studi di Pavia, 27100, Pavia, Italy.
| | - N Terranova
- Dipartimento di Ingegneria Industriale e dell'informazione, Università degli Studi di Pavia, 27100, Pavia, Italy
- Merck Institute for Pharmacometrics, Merck Serono S.A. (an affiliate of Merck KGaA, Darmstadt, Germany), Lausanne, Switzerland
| | - K Stuyckens
- Clinical Pharmacology and Pharmacometrics, Janssen Research and Development, Beerse, Belgium
| | - A G Dosne
- Clinical Pharmacology and Pharmacometrics, Janssen Research and Development, Beerse, Belgium
| | - T Perera
- Oncology Discovery, Janssen Research and Development, Beerse, Belgium
| | - J Vialard
- Oncology Discovery, Janssen Research and Development, Beerse, Belgium
| | - P King
- Oncology Discovery, Janssen Research and Development, Beerse, Belgium
| | - T Verhulst
- Oncology Discovery, Janssen Research and Development, Beerse, Belgium
| | - J J Perez-Ruixo
- Clinical Pharmacology and Pharmacometrics, Janssen Research and Development, Beerse, Belgium
| | - P Magni
- Dipartimento di Ingegneria Industriale e dell'informazione, Università degli Studi di Pavia, 27100, Pavia, Italy
| | - I Poggesi
- Clinical Pharmacology and Pharmacometrics, Janssen Research and Development, Beerse, Belgium
- Certara Italia S.p.A, Milano, Italy
| |
Collapse
|
10
|
Alrefai H, Beierle A, Nassour L, Eustace N, Patel Z, Anderson J, Hicks P, King P, Willey C. TMOD-21. A NOVEL IN-VITRO METHOD TO MODEL MACROPHAGES IN GLIOBLASTOMA. Neuro Oncol 2021. [DOI: 10.1093/neuonc/noab196.882] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
BACKGROUND
The GBM tumor microenvironment (TME) is comprised of a plethora of cancerous and non-cancerous cells that contribute to GBM growth, invasion, and chemoresistance. In-vitro models of GBM typically fail to incorporate multiple cell types. Others have addressed this problem by employing 3D bioprinting to incorporate astrocytes and macrophages in an extracellular matrix; however, they used serum-containing media and classically polarized anti-inflammatory macrophages. Serum has been shown to cause GBM brain-tumor initiating cells to lose their stem-like properties, highlighting the importance of excluding it from these models. Additionally, tumor-associated macrophages (TAMs) do not adhere to the traditional M2 phenotype.
METHODS
THP-1 monocytes and normal human astrocytes (NHAs) were transitioned into serum-free HL-1 and neurobasal-based media, respectively. Monocytes were stimulated towards a macrophage-like state with PMA and polarized by co-culturing them with GBM patient-derived xenograft(PDX) lines, using a transwell insert. CD206 expression was used to validate polarization and a cytokine array was used to characterize the cells.
RESULTS
There was no difference in proliferation rates at 72 hours for THP-1 monocytes grown in serum-free HL-1 media compared to serum-containing RPMI 1640 (p > 0.95). Macrophages polarized via transwell inserts expressed the lymphocyte chemoattractant protein, CCL2, whereas resting(M0), pro-inflammatory(M1), and anti-inflammatory(M2) macrophages did not. Additionally, these macrophages expressed more CXCL1 and IL-1ß relative to M1 macrophages. We have also demonstrated a method to maintain a tri-culture model of GBM PDX cells, NHAs, and TAMs in a serum-free media that supports the growth/maintenance of all cell types.
CONCLUSIONS
We have demonstrated a novel method by which we can polarize macrophages towards a tumor-supportive phenotype that differs in cytokine expression from traditionally polarized macrophages. This higher-fidelity method of modeling TAMs in GBM can aid in the development of targeted therapeutics that may one day enter the clinic in hopes of improving outcomes in GBM.
Collapse
Affiliation(s)
- Hasan Alrefai
- University of Alabama at Birmingham, Birmingham, AL, USA
| | - Andee Beierle
- University of Alabama at Birmingham, Birmingham, AL, USA
| | - Lauren Nassour
- University of Alabama at Birmingham, Birmingham, AL, USA
| | | | - Zeel Patel
- University of Alabama at Birmingham, Birmingham, AL, USA
| | | | - Patricia Hicks
- University of Alabama at Birmingham, Birmingham, AL, USA
| | - Peter King
- University of Alabama at Birmingham, Birmingham, AL, USA
| | | |
Collapse
|
11
|
Makai L, Lehto T, Fodor B, King P. Breakthrough instruments and products: Investigation of atomic layer deposited Al:ZnO layer by spectroscopic ellipsometry from the deep-UV to the mid-IR in one instrument. Rev Sci Instrum 2021; 92:119501. [PMID: 34852546 DOI: 10.1063/5.0071638] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/15/2021] [Accepted: 09/17/2021] [Indexed: 06/13/2023]
Abstract
The Semilab SE-2000 spectroscopic ellipsometer is a versatile thin film characterization instrument capable of spectroscopic ellipsometry measurements covering a large spectral range from ultraviolet to near infrared within a few seconds and into the mid-infrared in a few minutes. It is suitable for characterizing thin films from monolayers to complex multi-layer laminates and bulk materials. This article demonstrates the unique capabilities of the SE-2000 system by the wide spectral range investigation of Al doped ZnO layers on different substrates and with different layer structures. Using data fits to the Drude dispersion law, the electrical properties of Al:ZnO were determined despite the presence of other conductive layers. The results were corroborated with four-point-probe measurements on a single Al:ZnO layer deposited on a glass substrate.
Collapse
Affiliation(s)
- László Makai
- Semilab Semiconductor Physics Laboratory Co., Ltd., Prielle Kornélia u. 4/a., 1117 Budapest, Hungary
| | - Tero Lehto
- Picosun Oy, Masalantie 365, Masala FI-02430, Finland
| | - Bálint Fodor
- Semilab Semiconductor Physics Laboratory Co., Ltd., Prielle Kornélia u. 4/a., 1117 Budapest, Hungary
| | - Peter King
- Picosun Oy, Masalantie 365, Masala FI-02430, Finland
| |
Collapse
|
12
|
Zhang Z, Ghosh A, Connolly PJ, King P, Wilde T, Wang J, Dong Y, Li X, Liao D, Chen H, Tian G, Suarez J, Bonnette WG, Pande V, Diloreto KA, Shi Y, Patel S, Pietrak B, Szewczuk L, Sensenhauser C, Dallas S, Edwards JP, Bachman KE, Evans DC. Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal Cancer. J Med Chem 2021; 64:11570-11596. [PMID: 34279934 DOI: 10.1021/acs.jmedchem.1c00890] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Selective cyclooxygenase (COX)-2 inhibitors have been extensively studied for colorectal cancer (CRC) chemoprevention. Celecoxib has been reported to reduce the incidence of colorectal adenomas and CRC but is also associated with an increased risk of cardiovascular events. Here, we report a series of gut-restricted, selective COX-2 inhibitors characterized by high colonic exposure and minimized systemic exposure. By establishing acute ex vivo 18F-FDG uptake attenuation as an efficacy proxy, we identified a subset of analogues that demonstrated statistically significant in vivo dose-dependent inhibition of adenoma progression and survival extension in an APCmin/+ mouse model. However, in vitro-in vivo correlation analysis showed their chemoprotective effects were driven by residual systemic COX-2 inhibition, rationalizing their less than expected efficacies and highlighting the challenges associated with COX-2-mediated CRC disease chemoprevention.
Collapse
Affiliation(s)
- Zhuming Zhang
- Discovery Chemistry, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Avijit Ghosh
- Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Peter J Connolly
- Discovery Chemistry, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Peter King
- Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Thomas Wilde
- Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Jianyao Wang
- Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Yawei Dong
- Chemistry, Pharmaron Beijing, Co. Ltd., No. 6, TaiHe Road, BDA Beijing 100176, P. R. China
| | - Xueliang Li
- Chemistry, Pharmaron Beijing, Co. Ltd., No. 6, TaiHe Road, BDA Beijing 100176, P. R. China
| | - Daohong Liao
- Chemistry, Pharmaron Beijing, Co. Ltd., No. 6, TaiHe Road, BDA Beijing 100176, P. R. China
| | - Hao Chen
- Chemistry, Pharmaron Beijing, Co. Ltd., No. 6, TaiHe Road, BDA Beijing 100176, P. R. China
| | - Gaochao Tian
- Discovery Technology and Molecular Pharmacology, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Javier Suarez
- Discovery Technology and Molecular Pharmacology, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - William G Bonnette
- Discovery Technology and Molecular Pharmacology, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Vineet Pande
- Discovery Chemistry, Janssen Research and Development, Turnhoutseweg 30, B-2340 Beerse, Belgium
| | - Karen A Diloreto
- Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Yifan Shi
- Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Shefali Patel
- Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Beth Pietrak
- Discovery Technology and Molecular Pharmacology, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Lawrence Szewczuk
- Discovery Technology and Molecular Pharmacology, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Carlo Sensenhauser
- Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Shannon Dallas
- Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - James P Edwards
- Discovery Chemistry, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - Kurtis E Bachman
- Oncology Discovery, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| | - David C Evans
- Drug Metabolism and Pharmacokinetics, Janssen Research and Development, Spring House, Pennsylvania 19477, United States
| |
Collapse
|
13
|
Higginson A, Zhang S, Bailly-Grandvaux M, McGuffey C, Bhutwala K, Winjum BJ, Strehlow J, Edghill B, Dozières M, Tsung FS, Lee R, Andrews S, Spencer SJ, Lemos N, Albert F, King P, Wei MS, Mori WB, Manuel MJE, Beg FN. Electron acceleration at oblique angles via stimulated Raman scattering at laser irradiance >10^{16}Wcm^{-2}μm^{2}. Phys Rev E 2021; 103:033203. [PMID: 33862755 DOI: 10.1103/physreve.103.033203] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Accepted: 01/22/2021] [Indexed: 11/07/2022]
Abstract
The generation of hot, directional electrons via laser-driven stimulated Raman scattering (SRS) is a topic of great importance in inertial confinement fusion (ICF) schemes. Little recent research has been dedicated to this process at high laser intensity, in which back, side, and forward scatter simultaneously occur in high energy density plasmas, of relevance to, for example, shock ignition ICF. We present an experimental and particle-in-cell (PIC) investigation of hot electron production from SRS in the forward and near-forward directions from a single speckle laser of wavelength λ_{0}=1.053μm, peak laser intensities in the range I_{0}=0.2-1.0×10^{17}Wcm^{-2} and target electron densities between n_{e}=0.3-1.6%n_{c}, where n_{c} is the plasma critical density. As the intensity and density are increased, the hot electron spectrum changes from a sharp cutoff to an extended spectrum with a slope temperature T=34±1keV and maximum measured energy of 350 keV experimentally. Multidimensional PIC simulations indicate that the high energy electrons are primarily generated from SRS-driven electron plasma wave phase fronts with k vectors angled ∼50^{∘} with respect to the laser axis. These results are consistent with analytical arguments that the spatial gain is maximized at an angle which balances the tendency for the growth rate to be larger for larger scattered light wave angles until the kinetic damping of the plasma wave becomes important. The efficiency of generated high energy electrons drops significantly with a reduction in either laser intensity or target electron density, which is a result of the rapid drop in growth rate of Raman scattering at angles in the forward direction.
Collapse
Affiliation(s)
- A Higginson
- Center for Energy Research, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0417, USA
| | - S Zhang
- Center for Energy Research, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0417, USA
| | - M Bailly-Grandvaux
- Center for Energy Research, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0417, USA
| | - C McGuffey
- Center for Energy Research, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0417, USA
| | - K Bhutwala
- Center for Energy Research, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0417, USA
| | - B J Winjum
- Office of Advanced Research Computing, University of California Los Angeles, Los Angeles, California 90095, USA
| | - J Strehlow
- Center for Energy Research, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0417, USA
| | - B Edghill
- Center for Energy Research, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0417, USA
| | - M Dozières
- Center for Energy Research, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0417, USA
| | - F S Tsung
- Physics and Astronomy Department, University of California Los Angeles, Los Angeles, California 90095, USA
| | - R Lee
- Physics and Astronomy Department, University of California Los Angeles, Los Angeles, California 90095, USA
| | - S Andrews
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - S J Spencer
- Centre for Fusion, Space, and Astrophysics, University of Warwick, Coventry CV4 7AL, United Kingdom
| | - N Lemos
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - F Albert
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - P King
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA.,Department of Physics, University of Texas at Austin, Austin, Texas 78712, USA
| | - M S Wei
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - W B Mori
- Physics and Astronomy Department, University of California Los Angeles, Los Angeles, California 90095, USA
| | - M J-E Manuel
- General Atomics, Inertial Fusion Technologies, San Diego, California 92121, USA
| | - F N Beg
- Center for Energy Research, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0417, USA
| |
Collapse
|
14
|
Ibarburu S, Kovacs M, Varela V, Rodríguez-Duarte J, Ingold M, Invernizzi P, Porcal W, Arévalo AP, Perelmuter K, Bollati-Fogolín M, Escande C, López GV, King P, Si Y, Kwon Y, Batthyány C, Barbeito L, Trias E. A Nitroalkene Benzoic Acid Derivative Targets Reactive Microglia and Prolongs Survival in an Inherited Model of ALS via NF-κB Inhibition. Neurotherapeutics 2021; 18:309-325. [PMID: 33118131 PMCID: PMC8116482 DOI: 10.1007/s13311-020-00953-z] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/12/2020] [Indexed: 12/28/2022] Open
Abstract
Motor neuron degeneration and neuroinflammation are the most striking pathological features of amyotrophic lateral sclerosis (ALS). ALS currently has no cure and approved drugs have only a modest clinically therapeutic effect in patients. Drugs targeting different deleterious inflammatory pathways in ALS appear as promising therapeutic alternatives. Here, we have assessed the potential therapeutic effect of an electrophilic nitroalkene benzoic acid derivative, (E)-4-(2-nitrovinyl) benzoic acid (BANA), to slow down paralysis progression when administered after overt disease onset in SOD1G93A rats. BANA exerted a significant inhibition of NF-κB activation in NF-κB reporter transgenic mice and microglial cell cultures. Systemic daily oral administration of BANA to SOD1G93A rats after paralysis onset significantly decreased microgliosis and astrocytosis, and significantly reduced the number of NF-κB-p65-positive microglial nuclei surrounding spinal motor neurons. Numerous microglia bearing nuclear NF-κB-p65 were observed in the surrounding of motor neurons in autopsy spinal cords from ALS patients but not in controls, suggesting ALS-associated microglia could be targeted by BANA. In addition, BANA-treated SOD1G93A rats after paralysis onset showed significantly ameliorated spinal motor neuron pathology as well as conserved neuromuscular junction innervation in the skeletal muscle, as compared to controls. Notably, BANA prolonged post-paralysis survival by ~30%, compared to vehicle-treated littermates. These data provide a rationale to therapeutically slow paralysis progression in ALS using small electrophilic compounds such as BANA, through a mechanism involving microglial NF-κB inhibition.
Collapse
Affiliation(s)
- Sofía Ibarburu
- Neurodegeneration Laboratory, Institut Pasteur de Montevideo, Mataojo, 2020, Montevideo, Uruguay
| | - Mariángeles Kovacs
- Neurodegeneration Laboratory, Institut Pasteur de Montevideo, Mataojo, 2020, Montevideo, Uruguay
| | - Valentina Varela
- Neurodegeneration Laboratory, Institut Pasteur de Montevideo, Mataojo, 2020, Montevideo, Uruguay
| | - Jorge Rodríguez-Duarte
- Laboratory of Vascular Biology and Drug Development, INDICYO Program, Institut Pasteur de Montevideo, Montevideo, Uruguay
| | - Mariana Ingold
- Laboratory of Vascular Biology and Drug Development, INDICYO Program, Institut Pasteur de Montevideo, Montevideo, Uruguay
- Departmento de Química Orgánica, Facultad de Química, Universidad de la República, Montevideo, Uruguay
| | - Paulina Invernizzi
- Laboratory of Vascular Biology and Drug Development, INDICYO Program, Institut Pasteur de Montevideo, Montevideo, Uruguay
| | - Williams Porcal
- Laboratory of Vascular Biology and Drug Development, INDICYO Program, Institut Pasteur de Montevideo, Montevideo, Uruguay
- Departmento de Química Orgánica, Facultad de Química, Universidad de la República, Montevideo, Uruguay
| | - Ana Paula Arévalo
- Transgenic and Experimental Animal Unit, Institut Pasteur de Montevideo, Montevideo, Uruguay
| | - Karen Perelmuter
- Cell Biology Unit, Institut Pasteur de Montevideo, Montevideo, Uruguay
| | | | - Carlos Escande
- Laboratory of Metabolic Diseases and Aging, INDICyO Program, Institut Pasteur Montevideo, Montevideo, Uruguay
| | - Gloria V López
- Laboratory of Vascular Biology and Drug Development, INDICYO Program, Institut Pasteur de Montevideo, Montevideo, Uruguay
- Departmento de Química Orgánica, Facultad de Química, Universidad de la República, Montevideo, Uruguay
| | - Peter King
- Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
- Birmingham Veterans Affairs Medical Center, Birmingham, AL, 35294, USA
| | - Ying Si
- Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
- Birmingham Veterans Affairs Medical Center, Birmingham, AL, 35294, USA
| | - Yuri Kwon
- Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
| | - Carlos Batthyány
- Laboratory of Vascular Biology and Drug Development, INDICYO Program, Institut Pasteur de Montevideo, Montevideo, Uruguay
| | - Luis Barbeito
- Neurodegeneration Laboratory, Institut Pasteur de Montevideo, Mataojo, 2020, Montevideo, Uruguay.
| | - Emiliano Trias
- Neurodegeneration Laboratory, Institut Pasteur de Montevideo, Mataojo, 2020, Montevideo, Uruguay.
| |
Collapse
|
15
|
Yero C, Abrams D, Ahmed Z, Ahmidouch A, Aljawrneh B, Alsalmi S, Ambrose R, Armstrong W, Asaturyan A, Assumin-Gyimah K, Ayerbe Gayoso C, Bandari A, Bane J, Basnet S, Berdnikov VV, Bericic J, Bhatt H, Bhetuwal D, Biswas D, Boeglin WU, Bosted P, Brash E, Bukhari MHS, Chen H, Chen JP, Chen M, Christy ME, Covrig S, Craycraft K, Danagoulian S, Day D, Diefenthaler M, Dlamini M, Dunne J, Duran B, Dutta D, Ent R, Evans R, Fenker H, Fomin N, Fuchey E, Gaskell D, Gautam TN, Gonzalez FA, Hansen JO, Hauenstein F, Hernandez AV, Horn T, Huber GM, Jones MK, Joosten S, Kabir ML, Karki A, Keppel CE, Khanal A, King P, Kinney E, Lashley-Colthirst N, Li S, Li WB, Liyanage AH, Mack DJ, Malace SP, Matter J, Meekins D, Michaels R, Mkrtchyan A, Mkrtchyan H, Nazeer SJ, Nanda S, Niculescu G, Niculescu M, Nguyen D, Nuruzzaman N, Pandey B, Park S, Perdrisat CF, Pooser E, Rehfuss M, Reinhold J, Sawatzky B, Smith GR, Sun A, Szumila-Vance H, Tadevosyan V, Wood SA, Zhang J. Probing the Deuteron at Very Large Internal Momenta. Phys Rev Lett 2020; 125:262501. [PMID: 33449750 DOI: 10.1103/physrevlett.125.262501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/19/2020] [Revised: 10/27/2020] [Accepted: 12/02/2020] [Indexed: 06/12/2023]
Abstract
We measure ^{2}H(e,e^{'}p)n cross sections at 4-momentum transfers of Q^{2}=4.5±0.5 (GeV/c)^{2} over a range of neutron recoil momenta p_{r}, reaching up to ∼1.0 GeV/c. We obtain data at fixed neutron recoil angles θ_{nq}=35°, 45°, and 75° with respect to the 3-momentum transfer q[over →]. The new data agree well with previous data, which reached p_{r}∼500 MeV/c. At θ_{nq}=35° and 45°, final state interactions, meson exchange currents, and isobar currents are suppressed and the plane wave impulse approximation provides the dominant cross section contribution. We compare the new data to recent theoretical calculations, where we observe a significant discrepancy for recoil momenta p_{r}>700 MeV/c.
Collapse
Affiliation(s)
- C Yero
- Florida International University, University Park, Florida 33199, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D Abrams
- University of Virginia, Charlottesville, Virginia 22903, USA
| | - Z Ahmed
- University of Regina, Regina, Saskatchewan S4S 0A2, Canada
| | - A Ahmidouch
- North Carolina Agricultural and Technical State University, Greensboro, North Carolina 27411, USA
| | - B Aljawrneh
- North Carolina Agricultural and Technical State University, Greensboro, North Carolina 27411, USA
| | - S Alsalmi
- Kent State University, Kent, Ohio 44240, USA
| | - R Ambrose
- University of Regina, Regina, Saskatchewan S4S 0A2, Canada
| | - W Armstrong
- Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - A Asaturyan
- A.I. Alikhanyan National Science Laboratory (Yerevan Physics Institute), 2 Alikhanian Brothers Street, 0036, Yerevan, Armenia
| | - K Assumin-Gyimah
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | - C Ayerbe Gayoso
- College of William & Mary, Williamsburg, Virginia 23185, USA
| | - A Bandari
- College of William & Mary, Williamsburg, Virginia 23185, USA
| | - J Bane
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - S Basnet
- University of Regina, Regina, Saskatchewan S4S 0A2, Canada
| | - V V Berdnikov
- Catholic University of America, Washington, D.C. 20064, USA
| | - J Bericic
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - H Bhatt
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | - D Bhetuwal
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | - D Biswas
- Hampton University, Hampton, Virginia 23669, USA
| | - W U Boeglin
- Florida International University, University Park, Florida 33199, USA
| | - P Bosted
- College of William & Mary, Williamsburg, Virginia 23185, USA
| | - E Brash
- Christopher Newport University, Newport News, Virginia 23606, USA
| | | | - H Chen
- University of Virginia, Charlottesville, Virginia 22903, USA
| | - J P Chen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Chen
- University of Virginia, Charlottesville, Virginia 22903, USA
| | - M E Christy
- Hampton University, Hampton, Virginia 23669, USA
| | - S Covrig
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K Craycraft
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - S Danagoulian
- North Carolina Agricultural and Technical State University, Greensboro, North Carolina 27411, USA
| | - D Day
- University of Virginia, Charlottesville, Virginia 22903, USA
| | - M Diefenthaler
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Dlamini
- Ohio University, Athens, Ohio 45701, USA
| | - J Dunne
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | - B Duran
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - D Dutta
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | - R Ent
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Evans
- University of Regina, Regina, Saskatchewan S4S 0A2, Canada
| | - H Fenker
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - N Fomin
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - E Fuchey
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Gaskell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - T N Gautam
- Hampton University, Hampton, Virginia 23669, USA
| | - F A Gonzalez
- Stony Brook University, Stony Brook, New York 11794, USA
| | - J O Hansen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - F Hauenstein
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A V Hernandez
- Catholic University of America, Washington, D.C. 20064, USA
| | - T Horn
- Catholic University of America, Washington, D.C. 20064, USA
| | - G M Huber
- University of Regina, Regina, Saskatchewan S4S 0A2, Canada
| | - M K Jones
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Joosten
- Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - M L Kabir
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | - A Karki
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | - C E Keppel
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Khanal
- Florida International University, University Park, Florida 33199, USA
| | - P King
- Ohio University, Athens, Ohio 45701, USA
| | - E Kinney
- University of Colorado Boulder, Boulder, Colorado 80309, USA
| | | | - S Li
- University of New Hampshire, Durham, New Hampshire 03824, USA
| | - W B Li
- College of William & Mary, Williamsburg, Virginia 23185, USA
| | - A H Liyanage
- Hampton University, Hampton, Virginia 23669, USA
| | - D J Mack
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S P Malace
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Matter
- University of Virginia, Charlottesville, Virginia 22903, USA
| | - D Meekins
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Michaels
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Mkrtchyan
- A.I. Alikhanyan National Science Laboratory (Yerevan Physics Institute), 2 Alikhanian Brothers Street, 0036, Yerevan, Armenia
| | - H Mkrtchyan
- A.I. Alikhanyan National Science Laboratory (Yerevan Physics Institute), 2 Alikhanian Brothers Street, 0036, Yerevan, Armenia
| | - S J Nazeer
- Hampton University, Hampton, Virginia 23669, USA
| | - S Nanda
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - M Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - D Nguyen
- University of Virginia, Charlottesville, Virginia 22903, USA
| | - N Nuruzzaman
- Rutgers University, New Brunswick, New Jersey 08854, USA
| | - B Pandey
- Hampton University, Hampton, Virginia 23669, USA
| | - S Park
- Stony Brook University, Stony Brook, New York 11794, USA
| | - C F Perdrisat
- College of William & Mary, Williamsburg, Virginia 23185, USA
| | - E Pooser
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Rehfuss
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - J Reinhold
- Florida International University, University Park, Florida 33199, USA
| | - B Sawatzky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - G R Smith
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Sun
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - H Szumila-Vance
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Tadevosyan
- A.I. Alikhanyan National Science Laboratory (Yerevan Physics Institute), 2 Alikhanian Brothers Street, 0036, Yerevan, Armenia
| | - S A Wood
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Zhang
- Stony Brook University, Stony Brook, New York 11794, USA
| |
Collapse
|
16
|
Oh SJ, Lu L, Alsharabati M, Morgan MB, King P. Chronic inflammatory axonal polyneuropathy. J Neurol Neurosurg Psychiatry 2020; 91:1175-1180. [PMID: 32917820 DOI: 10.1136/jnnp-2020-323787] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/11/2020] [Revised: 06/17/2020] [Accepted: 06/30/2020] [Indexed: 12/22/2022]
Abstract
OBJECTIVES Chronic inflammatory axonal polyneuropathy (CIAP) is defined on the basis of the clinical, electrophysiological and nerve biopsy findings and therapeutic responses of 'immunotherapy responding chronic axonal polyneuropathy (IR-CAP)'. METHODS The diagnosis of IR-CAP was made when all of three of the following mandatory criterion were met: (1) acquired, chronic progressive or relapsing symmetrical or asymmetrical polyneuropathy with duration of progression >2 months; (2) electrophysiological evidence of axonal neuropathy in at least two nerves without any evidence of 'strict criteria of demyelination'; and (3) definite responsiveness to immunotherapy. RESULTS Thirty-three patients with IR-CAP showed similar clinical features of chronic inflammatory demyelinating polyneuropathy (CIDP) except 'motor neuropathy subtype'. High spinal fluid protein was found in 27/32 (78%) cases. 'Inflammatory axonal neuropathy' was proven in 14 (45%) of 31 sural nerve biopsies. DISCUSSIONS IR-CAP could well be 'axonal CIDP' in view of clinical similarity, but not proven as yet. Thus, IR-CAP is best described as CIAP, a distinct entity that deserves its recognition in view of responsiveness to immunotherapy. CONCLUSION Diagnosis of CIAP can be made by additional documentation of 'inflammation' by high spinal fluid protein or nerve biopsy in addition to the first two diagnostic criteria of IR-CAP.
Collapse
Affiliation(s)
- Shin J Oh
- Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | | | | | | | - Peter King
- Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| |
Collapse
|
17
|
Gago PA, Konstantinou C, Biscontin G, King P. Stress inhomogeneity effect on fluid-induced fracture behavior into weakly consolidated granular systems. Phys Rev E 2020; 102:040901. [PMID: 33212584 DOI: 10.1103/physreve.102.040901] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2020] [Accepted: 09/21/2020] [Indexed: 06/11/2023]
Abstract
We study the effect of stress inhomogeneity on the behavior of fluid-driven fracture development in weakly consolidated granular systems. Using numerical models we investigate the change in fracture growth rate and fracture pattern structure in unconsolidated granular packs (also referred to as soft-sands) as a function of the change in the confining stresses applied to the system. Soft-sands do not usually behave like brittle, linear elastic materials, and as a consequence, poroelastic models are often not applicable to describe their behavior. By making a distinction between "cohesive" and "compressive" grain-grain contact forces depending on their magnitude, we propose an expression that describes the fluid opening pressure as a function of the mean value and the standard deviation of the "compressive stress" distribution. We also show that the standard deviation of this distribution can be related with the extent to which fracture "branches" reach into the material.
Collapse
Affiliation(s)
- Paula A Gago
- Department of Earth Science and Engineering, Imperial College, London SW7 2BP, United Kingdom
| | | | - Giovanna Biscontin
- Department of Engineering, University of Cambridge, Cambridge CB2 1PZ, United Kingdom
| | - Peter King
- Department of Earth Science and Engineering, Imperial College, London SW7 2BP, United Kingdom
| |
Collapse
|
18
|
Rinker JR, Meador WR, King P. Randomized feasibility trial to assess tolerance and clinical effects of lithium in progressive multiple sclerosis. Heliyon 2020; 6:e04528. [PMID: 32760832 PMCID: PMC7393418 DOI: 10.1016/j.heliyon.2020.e04528] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2020] [Revised: 07/14/2020] [Accepted: 07/17/2020] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Disability accumulation in progressive multiple sclerosis (MS) results from inflammatory and neurodegenerative mechanisms. In animal models of MS, lithium acts to reduce inflammatory demyelination, and in models of neurodegenerative diseases, lithium also slows neuronal death. Prospective studies of lithium in MS patients have not been previously undertaken. OBJECTIVE To determine the tolerance and feasibility of using low-dose (150-300 mg/daily) lithium as a pharmaceutical intervention in a cohort of subjects with progressive MS, and to gauge preliminary effects of lithium on change in brain volume over time. METHODS Patients with primary or secondary progressive MS were recruited into a 2-year, single-blind crossover trial in which subjects were randomly assigned to take lithium in year 1 or 2. The primary outcomes of interest were tolerance of lithium and percentage brain volume change (PBVC) on vs. off lithium. Secondary outcomes included relapse rates, disability changes, and self-report scales assessing fatigue, mood, and quality of life (QOL). RESULTS Of 24 screened patients, 23 were randomized to take lithium during year 1 (n = 11) or 2 (n = 12). Two subjects discontinued the trial due to lithium side effects. Other reasons for discontinuation included personal reasons (n = 2), worsening MS (n = 1), and development of multiple myeloma (n = 1). For the 17 who completed the trial, change in PBVC on lithium (+0.107) did not significantly differ from the observation period (-0.355, p = 0.346). Disability measured by Expanded Disability Status Scale and MS Functional Composite did not differ by lithium treatment status. On patient reported measures of mental well-being, subjects reported fewer depressive symptoms on the Beck Depression Inventory (12.3 vs. 15.8, p = 0.016) and more favorably on the mental domains of the MSQOL inventory (56.7 vs. 52.4, p = 0.028). CONCLUSIONS Low-dose lithium is well tolerated in persons with MS. Taking lithium did not result in differences in PBVC, relapses, or disability, but conclusions were limited by study design and sample size. Despite concern for lithium-associated neurological side effects, subjects taking lithium did not report worsened fatigue or physical well-being. On measures of mood and mental health QOL, subjects scored more favorably while taking lithium. CLINICALTRIALSGOV IDENTIFIER NCT01259388.
Collapse
Affiliation(s)
- John R. Rinker
- Department of Neurology, University of Alabama at Birmingham, 1720 7 Avenue South, Birmingham, AL, 35294, USA
- Birmingham VA Medical Center, 700 19 Street South, Birmingham, AL, 35233, USA
| | - William R. Meador
- Department of Neurology, University of Alabama at Birmingham, 1720 7 Avenue South, Birmingham, AL, 35294, USA
| | - Peter King
- Birmingham VA Medical Center, 700 19 Street South, Birmingham, AL, 35233, USA
| |
Collapse
|
19
|
Cruz-Torres R, Nguyen D, Hauenstein F, Schmidt A, Li S, Abrams D, Albataineh H, Alsalmi S, Androic D, Aniol K, Armstrong W, Arrington J, Atac H, Averett T, Ayerbe Gayoso C, Bai X, Bane J, Barcus S, Beck A, Bellini V, Benmokhtar F, Bhatt H, Bhetuwal D, Biswas D, Blyth D, Boeglin W, Bulumulla D, Camsonne A, Castellanos J, Chen JP, Cohen EO, Covrig S, Craycraft K, Dongwi B, Duer M, Duran B, Dutta D, Fuchey E, Gal C, Gautam TN, Gilad S, Gnanvo K, Gogami T, Golak J, Gomez J, Gu C, Habarakada A, Hague T, Hansen O, Hattawy M, Hen O, Higinbotham DW, Hughes E, Hyde C, Ibrahim H, Jian S, Joosten S, Kamada H, Karki A, Karki B, Katramatou AT, Keppel C, Khachatryan M, Khachatryan V, Khanal A, King D, King P, Korover I, Kutz T, Lashley-Colthirst N, Laskaris G, Li W, Liu H, Liyanage N, Markowitz P, McClellan RE, Meekins D, Mey-Tal Beck S, Meziani ZE, Michaels R, Mihovilovič M, Nelyubin V, Nuruzzaman N, Nycz M, Obrecht R, Olson M, Ou L, Owen V, Pandey B, Pandey V, Papadopoulou A, Park S, Patsyuk M, Paul S, Petratos GG, Piasetzky E, Pomatsalyuk R, Premathilake S, Puckett AJR, Punjabi V, Ransome R, Rashad MNH, Reimer PE, Riordan S, Roche J, Sargsian M, Santiesteban N, Sawatzky B, Segarra EP, Schmookler B, Shahinyan A, Širca S, Skibiński R, Sparveris N, Su T, Suleiman R, Szumila-Vance H, Tadepalli AS, Tang L, Tireman W, Topolnicki K, Tortorici F, Urciuoli G, Weinstein LB, Witała H, Wojtsekhowski B, Wood S, Ye ZH, Ye ZY, Zhang J. Probing Few-Body Nuclear Dynamics via ^{3}H and ^{3}He (e,e^{'}p)pn Cross-Section Measurements. Phys Rev Lett 2020; 124:212501. [PMID: 32530643 DOI: 10.1103/physrevlett.124.212501] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Revised: 03/12/2020] [Accepted: 04/30/2020] [Indexed: 06/11/2023]
Abstract
We report the first measurement of the (e,e^{'}p) three-body breakup reaction cross sections in helium-3 (^{3}He) and tritium (^{3}H) at large momentum transfer [⟨Q^{2}⟩≈1.9 (GeV/c)^{2}] and x_{B}>1 kinematics, where the cross section should be sensitive to quasielastic (QE) scattering from single nucleons. The data cover missing momenta 40≤p_{miss}≤500 MeV/c that, in the QE limit with no rescattering, equals the initial momentum of the probed nucleon. The measured cross sections are compared with state-of-the-art ab initio calculations. Overall good agreement, within ±20%, is observed between data and calculations for the full p_{miss} range for ^{3}H and for 100≤p_{miss}≤350 MeV/c for ^{3}He. Including the effects of rescattering of the outgoing nucleon improves agreement with the data at p_{miss}>250 MeV/c and suggests contributions from charge-exchange (SCX) rescattering. The isoscalar sum of ^{3}He plus ^{3}H, which is largely insensitive to SCX, is described by calculations to within the accuracy of the data over the entire p_{miss} range. This validates current models of the ground state of the three-nucleon system up to very high initial nucleon momenta of 500 MeV/c.
Collapse
Affiliation(s)
- R Cruz-Torres
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - D Nguyen
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
- University of Education, Hue University, Hue City, Vietnam
| | - F Hauenstein
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Schmidt
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Li
- University of New Hampshire, Durham, New Hampshire 03824, USA
| | - D Abrams
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - H Albataineh
- Texas A & M University, Kingsville, Texas 78363, USA
| | - S Alsalmi
- King Saud University, Riyadh 11451, Kingdom of Saudi Arabia
| | - D Androic
- University of Zagreb, 10000 Zagreb, Croatia
| | - K Aniol
- California State University, Los Angeles, California 90032, USA
| | - W Armstrong
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - J Arrington
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - T Averett
- The College of William and Mary, Williamsburg, Virginia 23185, USA
| | - C Ayerbe Gayoso
- The College of William and Mary, Williamsburg, Virginia 23185, USA
| | - X Bai
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - J Bane
- University of Tennessee, Knoxville, Tennessee 37966, USA
| | - S Barcus
- The College of William and Mary, Williamsburg, Virginia 23185, USA
| | - A Beck
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - V Bellini
- INFN Sezione di Catania, 95123 Catania, Italy
| | - F Benmokhtar
- Duquesne University, Pittsburgh, Pennsylvania 15282, USA
| | - H Bhatt
- Mississippi State University, Mississippi 39762, USA
| | - D Bhetuwal
- Mississippi State University, Mississippi 39762, USA
| | - D Biswas
- Hampton University, Hampton, Virginia 23669, USA
| | - D Blyth
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - W Boeglin
- Florida International University, Miami, Florida 33199, USA
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Camsonne
- Jefferson Lab, Newport News, Virginia 23606, USA
| | - J Castellanos
- Florida International University, Miami, Florida 33199, USA
| | - J-P Chen
- Jefferson Lab, Newport News, Virginia 23606, USA
| | - E O Cohen
- School of Physics and Astronomy, Tel Aviv University, Tel Aviv 69978, Israel
| | - S Covrig
- Jefferson Lab, Newport News, Virginia 23606, USA
| | - K Craycraft
- University of Tennessee, Knoxville, Tennessee 37966, USA
| | - B Dongwi
- Hampton University, Hampton, Virginia 23669, USA
| | - M Duer
- School of Physics and Astronomy, Tel Aviv University, Tel Aviv 69978, Israel
| | - B Duran
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - D Dutta
- Mississippi State University, Mississippi 39762, USA
| | - E Fuchey
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - C Gal
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - T N Gautam
- Hampton University, Hampton, Virginia 23669, USA
| | - S Gilad
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - K Gnanvo
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - T Gogami
- Tohoku University, Sendai, Miyagi 980-8577, Japan
| | - J Golak
- M. Smoluchowski Institute of Physics, Jagiellonian University, PL-30348 Kraków, Poland
| | - J Gomez
- Jefferson Lab, Newport News, Virginia 23606, USA
| | - C Gu
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - A Habarakada
- Hampton University, Hampton, Virginia 23669, USA
| | - T Hague
- Kent State University, Kent, Ohio 44240, USA
| | - O Hansen
- Jefferson Lab, Newport News, Virginia 23606, USA
| | - M Hattawy
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - O Hen
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | | | - E Hughes
- Columbia University, New York, New York 10027, USA
| | - C Hyde
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - H Ibrahim
- Cairo University, 12613 Cairo, Egypt
| | - S Jian
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - S Joosten
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - H Kamada
- Department of Physics, Faculty of Engineering, Kyushu Institute of Technology, Kitakyushu 804-8550, Japan
| | - A Karki
- Mississippi State University, Mississippi 39762, USA
| | - B Karki
- Ohio University, Athens, Ohio 45701, USA
| | | | - C Keppel
- Jefferson Lab, Newport News, Virginia 23606, USA
| | - M Khachatryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V Khachatryan
- Stony Brook, State University of New York, New York 11794, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - D King
- Syracuse University, Syracuse, New York 13244, USA
| | - P King
- Ohio University, Athens, Ohio 45701, USA
| | - I Korover
- Nuclear Research Center-Negev, Beer-Sheva, Israel
| | - T Kutz
- Stony Brook, State University of New York, New York 11794, USA
| | | | - G Laskaris
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - W Li
- University of Regina, Regina, SK S4S 0A2, Canada
| | - H Liu
- Columbia University, New York, New York 10027, USA
| | - N Liyanage
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - P Markowitz
- Florida International University, Miami, Florida 33199, USA
| | | | - D Meekins
- Jefferson Lab, Newport News, Virginia 23606, USA
| | - S Mey-Tal Beck
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - Z-E Meziani
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
- Columbia University, New York, New York 10027, USA
| | - R Michaels
- Jefferson Lab, Newport News, Virginia 23606, USA
| | - M Mihovilovič
- University of Ljubljana, 1000 Ljubljana, Slovenia
- Faculty of Mathematics and Physics, Jožef Stefan Institute, Ljubljana, Slovenia
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, DE-55128 Mainz, Germany
| | - V Nelyubin
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - N Nuruzzaman
- Hampton University, Hampton, Virginia 23669, USA
| | - M Nycz
- Kent State University, Kent, Ohio 44240, USA
| | - R Obrecht
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Olson
- Saint Norbert College, De Pere, Wisconsin 54115, USA
| | - L Ou
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - V Owen
- The College of William and Mary, Williamsburg, Virginia 23185, USA
| | - B Pandey
- Hampton University, Hampton, Virginia 23669, USA
| | - V Pandey
- Department of Physics, University of Florida, Gainesville, Florida 32611, USA
| | - A Papadopoulou
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Park
- Stony Brook, State University of New York, New York 11794, USA
| | - M Patsyuk
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Paul
- The College of William and Mary, Williamsburg, Virginia 23185, USA
| | | | - E Piasetzky
- School of Physics and Astronomy, Tel Aviv University, Tel Aviv 69978, Israel
| | - R Pomatsalyuk
- Institute of Physics and Technology, Kharkov 61108, Ukraine
| | - S Premathilake
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - A J R Puckett
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - V Punjabi
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - R Ransome
- Rutgers University, New Brunswick, New Jersey 08901, USA
| | - M N H Rashad
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - P E Reimer
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - S Riordan
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - J Roche
- Ohio University, Athens, Ohio 45701, USA
| | - M Sargsian
- Florida International University, Miami, Florida 33199, USA
| | - N Santiesteban
- University of New Hampshire, Durham, New Hampshire 03824, USA
| | - B Sawatzky
- Jefferson Lab, Newport News, Virginia 23606, USA
| | - E P Segarra
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - B Schmookler
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Shahinyan
- Yerevan Physics Institute, 0036 Yerevan, Armenia
| | - S Širca
- University of Ljubljana, 1000 Ljubljana, Slovenia
- Faculty of Mathematics and Physics, Jožef Stefan Institute, SI-1000, Ljubljana, Slovenia
| | - R Skibiński
- M. Smoluchowski Institute of Physics, Jagiellonian University, PL-30348 Kraków, Poland
| | - N Sparveris
- Columbia University, New York, New York 10027, USA
| | - T Su
- Kent State University, Kent, Ohio 44240, USA
| | - R Suleiman
- Jefferson Lab, Newport News, Virginia 23606, USA
| | | | - A S Tadepalli
- Rutgers University, New Brunswick, New Jersey 08901, USA
| | - L Tang
- Jefferson Lab, Newport News, Virginia 23606, USA
| | - W Tireman
- Northern Michigan University, Marquette, Michigan 49855, USA
| | - K Topolnicki
- M. Smoluchowski Institute of Physics, Jagiellonian University, PL-30348 Kraków, Poland
| | - F Tortorici
- INFN Sezione di Catania, 95123 Catania, Italy
| | | | - L B Weinstein
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - H Witała
- M. Smoluchowski Institute of Physics, Jagiellonian University, PL-30348 Kraków, Poland
| | | | - S Wood
- Jefferson Lab, Newport News, Virginia 23606, USA
| | - Z H Ye
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - Z Y Ye
- University of Illinois-Chicago, Chicago, Illinois 60607, USA
| | - J Zhang
- Stony Brook, State University of New York, New York 11794, USA
| |
Collapse
|
20
|
Chittenden R, King P. No Plunging and Cold Maceration followed by No Plunging as Alternative Winemaking Techniques: Tannin Extraction and Pigment Composition of Syrah and Pinot Noir Wines. S AFR J ENOL VITIC 2020. [DOI: 10.21548/41-1-3541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
21
|
Gago PA, Wieladek K, King P. Fluid-induced fracture into weakly consolidated sand: Impact of confining stress on initialization pressure. Phys Rev E 2020; 101:012907. [PMID: 32069651 DOI: 10.1103/physreve.101.012907] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2019] [Indexed: 11/07/2022]
Abstract
This paper studies the process of fluid injection driven fractures in granular packs where particles are held together by external confining stresses and weak intergrain cohesion. We investigate the process of fracture formations in soft sand confined into a radial Hele-Shaw cell. Two main regimes are well known for fluid injection in soft sand. For low fluid injection pressures it behaves as a solid porous material while for high enough injection pressures grain rearrangement takes place. Grain rearrangements lead to the formation of fluid channels or "fractures," the structure and geometry of which depend on the material and fluid properties. Due to macroscopic grain displacements and the predominant role of dissipative frictional forces in granular system dynamics, these materials do not behave as conventional brittle, linear elastic materials and the transition between these two regimes cannot usually be described using poroelastic models. In this work we investigate the change in the minimum fluid pressure required to start grain mobilization as a function of the confining stresses applied to the system using a spatially resolved computational fluid dynamics-discrete element method numerical model. We show that this change is proportional to the applied stress when the confining stresses can be regarded as uniformly distributed among the particles in the system. A preliminary analytical expression for this change is presented.
Collapse
Affiliation(s)
- Paula A Gago
- Department of Earth Science and Engineering, Imperial College, London, SW7 2BP, United Kingdom
| | - Kuba Wieladek
- Department of Earth Science and Engineering, Imperial College, London, SW7 2BP, United Kingdom
| | - Peter King
- Department of Earth Science and Engineering, Imperial College, London, SW7 2BP, United Kingdom
| |
Collapse
|
22
|
Peach H, Board R, Cook M, Corrie P, Ellis S, Geh J, King P, Laitung G, Larkin J, Marsden J, Middleton M, Moncrieff M, Nathan P, Powell B, Pritchard-Jones R, Rodwell S, Steven N, Lorigan P. Current role of sentinel lymph node biopsy in the management of cutaneous melanoma: A UK consensus statement. J Plast Reconstr Aesthet Surg 2020; 73:36-42. [DOI: 10.1016/j.bjps.2019.06.020] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2019] [Accepted: 06/09/2019] [Indexed: 10/26/2022]
|
23
|
Eichler C, Paepke S, Ohlinger R, Mathias W, Scheffen I, Lux M, Hadad S, Kiernan T, Whisker L, Kaushik M, King P. Abstract P2-14-05: Can an internal surgical adhesive facilitate drain-free mastectomy and reduce overall invasiveness?-A prospective, randomized, controlled, multicenter non-inferiority trial. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p2-14-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Mastectomy closure without drains has many potential advantages. Flap fixation techniques have shown to be an effective alternative to drains. This study tested the non-inferiority of a surgical adhesive in overall invasiveness compared to standard wound closure with drains. Methods: This trial (ClinicalTrials.gov Identifier: NCT02958449) recruited seventy-seven patients undergoing eighty-four mastectomies +/- SLNB (n=84) at eleven international centers. Procedures were prospectively randomized to standard wound closure with drains (SWC; n=41) or wound closure without drains using a high strength lysine-based adhesive named TissuGlu® (TG; n= 43). The primary outcome measured assessed overall invasiveness using the number of post-operative clinical interventions, including drain removals and needle aspirations. Secondary endpoints included total wound drainage, cumulative days of treatment, days to drain removal and wound healing related complications. A patient questionnaire evaluating quality of life measures was also administered. Results: Subjects in the TissuGlu® group required significantly fewer post-operative clinical interventions (1.25 ± 1.39 TG vs. 2.03 ± 1.45 SWC, p = <.0001) compared to the Control group and had fewer cumulative days of treatment (defined as days of drains being in place and / or days on which an aspiration occurred; 2.14 ± 4.15 TG vs. 5.76 ± 4.02 SWC, p = <0.0001). Presence of a drain was associated with significantly higher pain and lower mobility scores. Conclusion: The study demonstrates that flap fixation with this adhesive can permit drain-free mastectomy closure, reducing overall invasiveness and patient morbidity.
Citation Format: Eichler C, Paepke S, Ohlinger R, Mathias W, Scheffen I, Lux M, Hadad S, Kiernan T, Whisker L, Kaushik M, King P. Can an internal surgical adhesive facilitate drain-free mastectomy and reduce overall invasiveness?-A prospective, randomized, controlled, multicenter non-inferiority trial [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P2-14-05.
Collapse
Affiliation(s)
- C Eichler
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - S Paepke
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - R Ohlinger
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - W Mathias
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - I Scheffen
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - M Lux
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - S Hadad
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - T Kiernan
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - L Whisker
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - M Kaushik
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - P King
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| |
Collapse
|
24
|
King P, Brooke C, Tiwari D. 119CHARACTERISTICS AND OUTCOMES FOLLOWING EMERGENCY ADMISSION AMONGST OLDEST OLD IN A DISTRICT GENERAL HOSPITAL. Age Ageing 2019. [DOI: 10.1093/ageing/afy204.12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- P King
- Foundation Programme, Royal Bournemouth Hospital
| | - C Brooke
- Foundation Programme, Royal Bournemouth Hospital
| | - D Tiwari
- Dept Elderly Care, Royal Bournemouth Hospital
| |
Collapse
|
25
|
Affiliation(s)
- Peter King
- Australian Maritime College University of Tasmania Australia
| | - Andrew Vardy
- Department of Computer Science, Department of Electrical and Computer Engineering Memorial University of Newfoundland St. John's NL A1C 5S7 Canada
| | - Alexander L. Forrest
- Australian Maritime College University of Tasmania Australia
- Department of Civil and Environmental Engineering University of California, Davis Davis California 95616 USA
| |
Collapse
|
26
|
Johnston ZC, Bellingham M, Filis P, Soffientini U, Hough D, Bhattacharya S, Simard M, Hammond GL, King P, O'Shaughnessy PJ, Fowler PA. The human fetal adrenal produces cortisol but no detectable aldosterone throughout the second trimester. BMC Med 2018; 16:23. [PMID: 29429410 PMCID: PMC5808459 DOI: 10.1186/s12916-018-1009-7] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/07/2017] [Accepted: 01/18/2018] [Indexed: 12/19/2022] Open
Abstract
BACKGROUND Human fetal adrenal glands are highly active and, with the placenta, regulate circulating progesterone, estrogen and corticosteroids in the fetus. At birth the adrenals are essential for neonate salt retention through secretion of aldosterone, while adequate glucocorticoids are required to prevent adrenal insufficiency. The objective of this study was to carry out the first comprehensive analysis of adrenal steroid levels and steroidogenic enzyme expression in normal second trimester human fetuses. METHODS This was an observational study of steroids, messenger RNA transcripts and proteins in adrenals from up to 109 second trimester fetuses (11 weeks to 21 weeks) at the Universities of Aberdeen and Glasgow. The study design was balanced to show effects of maternal smoking. RESULTS Concentrations of 19 intra-adrenal steroids were quantified using liquid chromatography and mass spectrometry. Pregnenolone was the most abundant steroid while levels of 17α-hydroxyprogesterone, dehydroepiandrosterone sulphate (DHEAS) and progesterone were also high. Cortisol was present in all adrenals, but aldosterone was undetected and Δ4 androgens were low/undetected. CYP17A1, CYP21A2 and CYP11A1 were all highly expressed and the proteins localized to the adrenal fetal zone. There was low-level expression of HSD3B and CYP11B2, with HSD3B located mainly in the definitive zone. Maternal smoking altered fetal plasma adrenocorticotropic hormone (ACTH) (P = 0.052) and intra-adrenal progesterone, 17α-hydroxyprogesterone and 16α-hydroxyprogesterone, but not plasma or intra-adrenal cortisol, or intra-adrenal DHEAS. Fetal adrenal GATA6 and NR5A1 were increased by maternal smoking. CONCLUSIONS The human fetal adrenal gland produces cortisol but very low levels of Δ4 androgens and no detectable aldosterone throughout the second trimester. The presence of cortisol in fetal adrenals suggests that adrenal regulation of circulating fetal ACTH remains a factor in development of congenital adrenal hyperplasia during the second trimester, while a relative lack of aldosterone explains the salt-wasting disorders frequently seen in extreme pre-term neonates. Finally, maternal smoking may alter fetal adrenal sensitivity to ACTH, which could have knock-on effects on post-natal health.
Collapse
Affiliation(s)
- Zoe C Johnston
- Institute of Biodiversity, Animal Health & Comparative Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G61 1QH, UK
| | - Michelle Bellingham
- Institute of Biodiversity, Animal Health & Comparative Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G61 1QH, UK
| | - Panagiotis Filis
- Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK
| | - Ugo Soffientini
- Institute of Biodiversity, Animal Health & Comparative Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G61 1QH, UK
| | - Denise Hough
- Institute of Biodiversity, Animal Health & Comparative Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G61 1QH, UK
| | - Siladitya Bhattacharya
- Institute of Applied Health Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK
| | - Marc Simard
- Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, British Columbia, V6T 1Z3, Canada
| | - Geoffrey L Hammond
- Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, British Columbia, V6T 1Z3, Canada
| | - Peter King
- Centre for Endocrinology, William Harvey Research Institute, Barts and the London, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK
| | - Peter J O'Shaughnessy
- Institute of Biodiversity, Animal Health & Comparative Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G61 1QH, UK
| | - Paul A Fowler
- Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK.
| |
Collapse
|
27
|
Rogers E, Wright C, King P. Fentanyl lozenge story part 2: from military procurement to package. J ROY ARMY MED CORPS 2018; 164:458-462. [PMID: 29440467 DOI: 10.1136/jramc-2017-000901] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2017] [Revised: 01/26/2018] [Accepted: 01/27/2018] [Indexed: 11/04/2022]
Abstract
This paper describes the selection of fentanyl as a replacement for morphine as the United Kingdom Ministry of Defence's first-line battlefield analgesic agent. It is a detailed review of the 6 year journey from selection to eventual roll-out in October 2017. It concentrates on the procurement and governance process of the deployment of fentanyl for individual issue and self-use. It highlights the significant differences in military and civilian legislation, the specialist environment we work in and the safety concerns surrounding controlled drugs in the austere environment. The lessons learnt can be applied to other organisations working in specialist environments that are looking to improve patient care through novel or off-license techniques that meet legislative resistance.
Collapse
Affiliation(s)
- Edward Rogers
- Army Medical Service, Defence Medical Services, London, UK
| | - C Wright
- Army Medical Service, Defence Medical Services, London, UK
| | - P King
- Army Headquarters, British Army, Andover, UK
| |
Collapse
|
28
|
Ardelt A, Carpenter R, Iwuchukwu I, Zhang A, Lin W, Kosciuczuk E, Hinkson C, Rebeiz T, Reitz S, King P. Characterization of the transient middle cerebral artery occlusion model of ischemic stroke in a HuR transgenic mouse line. Data Brief 2017; 16:1083-1090. [PMID: 29854897 PMCID: PMC5972843 DOI: 10.1016/j.dib.2017.10.033] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
This set of experiments characterizes a model of transient cerebral ischemic stroke in a transgenic (Tg) mouse line in which the glial fibrillary acidic protein (GFAP) promoter is utilized to drive expression of a human RNA-binding protein, HuR. Additionally, the effect of cerebral ischemia on the expression of endogenous Hu proteins is presented.
Collapse
Affiliation(s)
- A Ardelt
- Department of Neurology, University of Chicago, 5841 S. Maryland Ave, MC2030, Chicago, IL 60637, USA
| | - R Carpenter
- Department of Neurology, University of Chicago, 5841 S. Maryland Ave, MC2030, Chicago, IL 60637, USA
| | - I Iwuchukwu
- Department of Neurocritical Care, Ochsner Medical Center, 1514 Jefferson Hwy., New Orleans, LA 70121, USA
| | - A Zhang
- Department of Neurology, University of Chicago, 5841 S. Maryland Ave, MC2030, Chicago, IL 60637, USA
| | - W Lin
- Department of Neurology, University of Chicago, 5841 S. Maryland Ave, MC2030, Chicago, IL 60637, USA
| | - E Kosciuczuk
- Division of Hematology-Oncology, Northwestern University, 675 North St. Clair, Chicago, IL 60611, USA
| | - C Hinkson
- Department of Neurology, University of Chicago, 5841 S. Maryland Ave, MC2030, Chicago, IL 60637, USA
| | - T Rebeiz
- Department of Neurology, University of Chicago, 5841 S. Maryland Ave, MC2030, Chicago, IL 60637, USA
| | - S Reitz
- Department of Neurology, University of Chicago, 5841 S. Maryland Ave, MC2030, Chicago, IL 60637, USA
| | - P King
- Department of Neurology, University of Alabama at Birmingham, 1720 7th Sve South and the Birmingham VA Medical Center, Birmingham, AL 35233, USA
| |
Collapse
|
29
|
Filippova N, Yang X, Ananthan S, Sorochinsky A, Hackney JR, Gentry Z, Bae S, King P, Nabors LB. Hu antigen R (HuR) multimerization contributes to glioma disease progression. J Biol Chem 2017; 292:16999-17010. [PMID: 28790173 DOI: 10.1074/jbc.m117.797878] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2017] [Revised: 07/27/2017] [Indexed: 12/21/2022] Open
Abstract
Among primary brain cancers, gliomas are the most deadly and most refractory to current treatment modalities. Previous reports overwhelmingly support the role of the RNA-binding protein Hu antigen R (HuR) as a positive regulator of glioma disease progression. HuR expression is consistently elevated in tumor tissues, and a cytoplasmic localization appears essential for HuR-dependent oncogenic transformation. Here, we report HuR aggregation (multimerization) in glioma and the analysis of this tumor-specific HuR protein multimerization in clinical brain tumor samples. Using a split luciferase assay, a bioluminescence resonance energy transfer technique, and site-directed mutagenesis, we examined the domains involved in HuR multimerization. Results obtained with the combination of the split HuR luciferase assay with the bioluminescence resonance energy transfer technique suggested that multiple (at least three) HuR molecules come together during HuR multimerization in glioma cells. Using these data, we developed a model of HuR multimerization in glioma cells. We also demonstrate that exposing glioma cells to the HuR inhibitor tanshinone group compound 15,16-dihydrotanshinone-I or to the newly identified compound 5 disrupts HuR multimerization modules and reduces tumor cell survival and proliferation. In summary, our findings provide new insights into HuR multimerization in glioma and highlight possible pharmacological approaches for targeting HuR domains involved in cancer cell-specific multimerization.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Sejong Bae
- Medicine, School of Medicine, University of Alabama, Birmingham, Alabama 35294
| | - Peter King
- From the Departments of Neurology.,Birmingham Veterans Affairs Medical Center, Birmingham, Alabama 35294
| | | |
Collapse
|
30
|
Bardin LD, King P, Maher CG. Diagnostic triage for low back pain: a practical approach for primary care. Med J Aust 2017; 206:268-273. [PMID: 28359011 DOI: 10.5694/mja16.00828] [Citation(s) in RCA: 123] [Impact Index Per Article: 17.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2016] [Accepted: 10/26/2016] [Indexed: 01/02/2023]
Abstract
Diagnostic triage is an essential guideline recommendation for low back pain (LBP), which is the most frequent musculoskeletal condition that general practitioners encounter in Australia. Clinical diagnosis of LBP - informed by a focused history and clinical examination - is the key initial step for GPs, and determines subsequent diagnostic workup and allied health and medical specialist referral. The goal of diagnostic triage of LBP is to exclude non-spinal causes and to allocate patients to one of three broad categories: specific spinal pathology (< 1% of cases), radicular syndrome (∼ 5-10% of cases) or non-specific LBP (NSLBP), which represents 90-95% of cases and is diagnosed by exclusion of the first two categories. For specific spinal pathologies (eg, vertebral fracture, malignancy, infection, axial spondyloarthritis or cauda equina syndrome), a clinical assessment may reveal the key alerting features. For radicular syndrome, clinical features distinguish three subsets of nerve root involvement: radicular pain, radiculopathy and spinal stenosis. Differential diagnosis of back-related leg pain is complex and clinical manifestations are highly variable. However, distinctive clusters of characteristic history cues and positive clinical examination signs, particularly from neurological examination, guide differential diagnosis within this triage category. A diagnosis of NSLBP presumes exclusion of specific pathologies and nerve root involvement. A biopsychosocial model of care underpins NSLBP; this includes managing pain intensity and considering risk for disability, which directs matched pathways of care. Back pain is a symptom and not a diagnosis. Careful diagnostic differentiation is required and, in primary care, diagnostic triage of LBP is the anchor for a diagnosis.
Collapse
|
31
|
Perera TP, Jovcheva E, Mevellec L, Vialard J, De Lange D, Verhulst T, Paulussen C, Van De Ven K, King P, Freyne E, Rees DC, Squires M, Saxty G, Page M, Murray CW, Gilissen R, Ward G, Thompson NT, Newell DR, Cheng N, Xie L, Yang J, Platero SJ, Karkera JD, Moy C, Angibaud P, Laquerre S, Lorenzi MV. Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor. Mol Cancer Ther 2017; 16:1010-1020. [DOI: 10.1158/1535-7163.mct-16-0589] [Citation(s) in RCA: 156] [Impact Index Per Article: 22.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2016] [Revised: 12/28/2016] [Accepted: 03/15/2017] [Indexed: 11/16/2022]
|
32
|
Sumalatha B, Kumar YP, King P. Studies on Biosorption of Arsenic from Aqueous Solutions using Citrus limonium as Biosorbent. ACTA ACUST UNITED AC 2017. [DOI: 10.5958/0974-360x.2017.00477.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
33
|
Affiliation(s)
- Kevin Doughty
- Medical Physics & Electronics Unit, School of Electronic Engineering & Computer Systems, University of Wales, Bangor, UK
| | - Peter King
- Medical Physics & Electronics Unit, School of Electronic Engineering & Computer Systems, University of Wales, Bangor, UK
| | - Gareth Williams
- Medical Physics & Electronics Unit, School of Electronic Engineering & Computer Systems, University of Wales, Bangor, UK
| |
Collapse
|
34
|
Waldegrave C, King P, Maniapoto M, Tamasese TK, Parsons TL, Sullivan G. Relational Resilience in Māori, Pacific, and European Sole Parent Families: From Theory and Research to Social Policy. Fam Process 2016; 55:673-688. [PMID: 27198906 DOI: 10.1111/famp.12219] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
This study reports findings and policy recommendations from a research project that applied a relational resilience framework to a study of 60 sole parent families in New Zealand, with approximately equal numbers of Māori, Pacific, and European (White) participants. The sole parent families involved were already known to be resilient and the study focused on identifying the relationships and strategies underlying the achievement and maintenance of their resilience. The study was carried out to provide an evidence base for the development and implementation of policies and interventions to both support sole parent families who have achieved resilience and assist those who struggle to do so. The three populations shared many similarities in their pathways to becoming sole parents and the challenges they faced as sole parents. The coping strategies underlying their demonstrated resilience were also broadly similar, but the ways in which they were carried out did vary in a manner that particularly reflected cultural practices in terms of their reliance upon extended family-based support or support from outside the family. The commonalities support the appropriateness of the common conceptual framework used, whereas the differences underline the importance of developing nuanced policy responses that take into account cultural differences between the various populations to which policy initiatives are directed.
Collapse
Affiliation(s)
- Charles Waldegrave
- Family Centre Social Policy Research Unit, Lower Hutt, Wellington, New Zealand
| | - Peter King
- Parallax Research, Lower Hutt, Wellington, New Zealand
| | - Maria Maniapoto
- Family Centre Social Policy Research Unit, Lower Hutt, Wellington, New Zealand
| | | | | | | |
Collapse
|
35
|
Abstract
The reliable and controllable fabrication of silicon nanowires is achieved, using mature CMOS technology processes. This will enable a low-cost route to integrating novel nanostructures with CMOS logic. The challenge of process repeatability has been overcome by careful study of material properties for processes such as etching and oxidation. By controlling anisotropic wet etching conditions, selection of nitride mask layer properties and sidewall oxidation, a robust process was achieved to realize silicon nanowires with sub 10 nm features. Surface roughness of nanowires was improved by a suitable oxidation step. The influence of process conditions on the shape of the nanowire was studied using TCAD simulation.
Collapse
Affiliation(s)
- Sami Ramadan
- School of Electrical and Electronic Engineering, Newcastle University, Newcastle upon Tyne NE1 7RU, UK
| | | | | | | |
Collapse
|
36
|
Spencer PS, Mazumder R, Palmer VS, Lasarev MR, Stadnik RC, King P, Kabahenda M, Kitara DL, Stadler D, McArdle B, Tumwine JK. Environmental, dietary and case-control study of Nodding Syndrome in Uganda: A post-measles brain disorder triggered by malnutrition? J Neurol Sci 2016; 369:191-203. [PMID: 27653888 DOI: 10.1016/j.jns.2016.08.023] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2016] [Accepted: 08/10/2016] [Indexed: 11/29/2022]
Abstract
Nodding Syndrome (NS) is an epileptic encephalopathy characterized by involuntary vertical head nodding, other types of seizures, and progressive neurological deficits. The etiology of the east African NS epidemic is unknown. In March 2014, we conducted a case-control study of medical, nutritional and other risk factors associated with NS among children (aged 5-18years) of Kitgum District, northern Uganda (Acholiland). Data on food availability, rainfall, and prevalent disease temporally related to the NS epidemic were also analyzed. In NS Cases, the mean age of reported head nodding onset was 7.6years (range 1-17years). The epidemiologic curve of NS incidence spanned 2000-2013, with peaks in 2003 and 2008. Month of onset of head nodding was non-uniform, with all-year-aggregated peaks in April and June when food availability was low. Families with one or more NS Cases had been significantly more dependent on emergency food and, immediately prior to head nodding onset in the child, subsistence on moldy plant materials, specifically moldy maize. Medical history revealed a single significant association with NS, namely prior measles infection. NS is compared with the post-measles disorder subacute sclerosing panencephalitis, with clinical expression triggered by factors associated with poor nutrition.
Collapse
Affiliation(s)
- Peter S Spencer
- Global Health Center (former), Oregon Health & Science University, Portland, OR, USA; Department of Neurology, School of Medicine, Oregon Health & Science University, Portland, OR, USA; Oregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA; Faculty of Medicine, Gulu University, Gulu, Uganda.
| | - Rajarshi Mazumder
- Global Health Center (former), Oregon Health & Science University, Portland, OR, USA
| | - Valerie S Palmer
- Global Health Center (former), Oregon Health & Science University, Portland, OR, USA; Department of Neurology, School of Medicine, Oregon Health & Science University, Portland, OR, USA; Faculty of Medicine, Gulu University, Gulu, Uganda
| | - Michael R Lasarev
- Oregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA
| | - Ryan C Stadnik
- Global Health Center (former), Oregon Health & Science University, Portland, OR, USA
| | - Peter King
- Global Health Center (former), Oregon Health & Science University, Portland, OR, USA
| | - Margaret Kabahenda
- Department of Food Technology and Nutrition, College of Agricultural and Environmental Sciences, Makerere University, Kampala, Uganda
| | - David L Kitara
- Oregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA
| | - Diane Stadler
- Graduate Program in Human Nutrition, School of Medicine, Oregon Health & Science University, Portland, OR, USA
| | - Breanna McArdle
- Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland, OR, USA
| | - James K Tumwine
- Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Makerere University, Kampala, Uganda
| | | |
Collapse
|
37
|
King P, Butters J, Psaltis P, Brown A, Brennan D, Nicholls S. Incidence of Early Cardiovascular Events Following Acute Coronary Syndromes in Men and Women: Insights From VISTA-16. Heart Lung Circ 2016. [DOI: 10.1016/j.hlc.2016.06.635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
38
|
Gijsen M, King P, Perera T, Parker PJ, Harris AL, Larijani B, Kong A. Correction: HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer. PLoS Biol 2016; 14:e1002414. [PMID: 26949965 PMCID: PMC4780807 DOI: 10.1371/journal.pbio.1002414] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
39
|
Onion D, Argent RH, Reece-Smith AM, Craze ML, Pineda RG, Clarke PA, Ratan HL, Parsons SL, Lobo DN, Duffy JP, Atherton JC, McKenzie AJ, Kumari R, King P, Hall BM, Grabowska AM. 3-Dimensional Patient-Derived Lung Cancer Assays Reveal Resistance to Standards-of-Care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase Inhibitors. Mol Cancer Ther 2016; 15:753-63. [PMID: 26873730 DOI: 10.1158/1535-7163.mct-15-0598] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2015] [Accepted: 11/10/2015] [Indexed: 11/16/2022]
Abstract
There is a growing recognition that current preclinical models do not reflect the tumor microenvironment in cellular, biological, and biophysical content and this may have a profound effect on drug efficacy testing, especially in the era of molecular-targeted agents. Here, we describe a method to directly embed low-passage patient tumor-derived tissue into basement membrane extract, ensuring a low proportion of cell death to anoikis and growth complementation by coculture with patient-derived cancer-associated fibroblasts (CAF). A range of solid tumors proved amenable to growth and pharmacologic testing in this 3D assay. A study of 30 early-stage non-small cell lung cancer (NSCLC) specimens revealed high levels of de novo resistance to a large range of standard-of-care agents, while histone deacetylase (HDAC) inhibitors and their combination with antineoplastic drugs displayed high levels of efficacy. Increased resistance was seen in the presence of patient-derived CAFs for many agents, highlighting the utility of the assay for tumor microenvironment-educated drug testing. Standard-of-care agents showed similar responses in the 3D ex vivo and patient-matched in vivo models validating the 3D-Tumor Growth Assay (3D-TGA) as a high-throughput screen for close-to-patient tumors using significantly reduced animal numbers. Mol Cancer Ther; 15(4); 753-63. ©2016 AACR.
Collapse
Affiliation(s)
- David Onion
- Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom. University of Nottingham Flow Cytometry Facility, School of Life Sciences, University of Nottingham, Nottingham, United Kingdom
| | - Richard H Argent
- Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom
| | - Alexander M Reece-Smith
- Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom
| | - Madeleine L Craze
- Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom
| | - Robert G Pineda
- Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom
| | - Philip A Clarke
- Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom
| | - Hari L Ratan
- Department of Urology, Nottingham University NHS Trust, QMC, Nottingham, United Kingdom
| | - Simon L Parsons
- Nottingham University NHS Trust, City Hospital Campus, Nottingham, United Kingdom
| | - Dileep N Lobo
- Nottingham Digestive Diseases National Institute of Health Research Biomedical Research Unit, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
| | - John P Duffy
- Department of Thoracic Surgery, Nottingham University NHS Trust, City Hospital Campus, Nottingham United Kingdom
| | - John C Atherton
- Nottingham Digestive Diseases National Institute of Health Research Biomedical Research Unit, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
| | | | - Rajendra Kumari
- Crown Bioscience UK Ltd, Hillcrest, Loughborough, United Kingdom
| | - Peter King
- Janssen Research and Development, Spring House, Pennsylvania
| | - Brett M Hall
- Janssen Research and Development, Spring House, Pennsylvania
| | - Anna M Grabowska
- Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
| |
Collapse
|
40
|
Casneuf T, Axel AE, King P, Alvarez JD, Werbeck JL, Verhulst T, Verstraeten K, Hall BM, Sasser AK. Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer. Breast Cancer (Dove Med Press) 2016; 8:13-27. [PMID: 26893580 PMCID: PMC4745841 DOI: 10.2147/bctt.s92414] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Introduction Interleukin-6 (IL-6) is an important growth factor for estrogen receptor-α (ERα)-positive breast cancer, and elevated serum IL-6 is associated with poor prognosis. Methods The role of the phosphorylated signal transducer and activator of transcription 3 pathway was investigated in ERα-positive breast cancer. A panel of cell lines was treated with exogenous IL-6. An IL-6 specific gene signature was generated by profiling ten ERα-positive breast cancer cell lines alone or following treatment with 10 ng/mL recombinant IL-6 or human marrow stromal cell-conditioned media, with or without siltuximab (a neutralizing anti-IL-6 antibody) and grown in three-dimensional tumor microenvironment-aligned cultures for 4 days, 5 days, or 6 days. The established IL-6 signature was validated against 36 human ERα-positive breast tumor samples with matched serum. A comparative MCF-7 xenograft murine model was utilized to determine the role of IL-6 in estrogen-supplemented ERα-positive breast cancer to assess the efficacy of anti-IL-6 therapy in vivo. Results In eight of nine ERα-positive breast cancer cell lines, recombinant IL-6 increased phosphorylation of tyrosine 705 of STAT3. Differential gene expression analysis identified 17 genes that could be used to determine IL-6 pathway activation by combining their expression intensity into a pathway activation score. The gene signature included a variety of genes involved in immune cell function and migration, cell growth and apoptosis, and the tumor microenvironment. Validation of the IL-6 gene signature in 36 matched human serum and ERα-positive breast tumor samples showed that patients with a high IL-6 pathway activation score were also enriched for elevated serum IL-6 (≥10 pg/mL). When human IL-6 was provided in vivo, MCF-7 cells engrafted without the need for estrogen supplementation, and addition of estrogen to IL-6 did not further enhance engraftment. Subsequently, we prophylactically treated mice at MCF-7 engraftment with siltuximab, fulvestrant, or combination therapy. Siltuximab alone was able to blunt MCF-7 engraftment. Similarly, siltuximab alone induced regressions in 90% (9/10) of tumors, which were established in the presence which were established in the presence of hMSC expressing human IL-6 and estrogen. Conclusion Given the established role for IL-6 in ERα-positive breast cancer, these data demonstrate the potential for anti-IL-6 therapeutics in breast cancer.
Collapse
Affiliation(s)
| | - Amy E Axel
- Janssen Research and Development, Spring House, PA, USA
| | - Peter King
- Janssen Research and Development, Spring House, PA, USA
| | | | | | | | | | - Brett M Hall
- Janssen Research and Development, Spring House, PA, USA
| | - A Kate Sasser
- Janssen Research and Development, Spring House, PA, USA
| |
Collapse
|
41
|
Sands N, Elsom S, Keppich-Arnold S, Henderson K, King P, Bourke-Finn K, Brunning D. Investigating the validity and usability of an interactive computer programme for assessing competence in telephone-based mental health triage. Int J Ment Health Nurs 2016; 25:80-6. [PMID: 26365233 DOI: 10.1111/inm.12165] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Telephone-based mental health triage services are frontline health-care providers that operate 24/7 to facilitate access to psychiatric assessment and intervention for people requiring assistance with a mental health problem. The mental health triage clinical role is complex, and the populations triage serves are typically high risk; yet to date, no evidence-based methods have been available to assess clinician competence to practice telephone-based mental health triage. The present study reports the findings of a study that investigated the validity and usability of the Mental Health Triage Competency Assessment Tool, an evidence-based, interactive computer programme designed to assist clinicians in developing and assessing competence to practice telephone-based mental health triage.
Collapse
Affiliation(s)
- Natisha Sands
- School of Nursing and Midwifery, Deakin University, Geelong
| | - Stephen Elsom
- Centre for Psychiatric Nursing, The University of Melbourne, Melbourne
| | | | | | - Peter King
- Crisis Assessment and Treatment Team, Alfred Health, Melbourne
| | | | | |
Collapse
|
42
|
|
43
|
Zhang YW, Long E, Mihovilovič M, Jin G, Allada K, Anderson B, Annand JRM, Averett T, Ayerbe-Gayoso C, Boeglin W, Bradshaw P, Camsonne A, Canan M, Cates GD, Chen C, Chen JP, Chudakov E, De Leo R, Deng X, Deur A, Dutta C, El Fassi L, Flay D, Frullani S, Garibaldi F, Gao H, Gilad S, Gilman R, Glamazdin O, Golge S, Gomez J, Hansen O, Higinbotham DW, Holmstrom T, Huang J, Ibrahim H, de Jager CW, Jensen E, Jiang X, St John J, Jones M, Kang H, Katich J, Khanal HP, King P, Korsch W, LeRose J, Lindgren R, Lu HJ, Luo W, Markowitz P, Meziane M, Michaels R, Moffit B, Monaghan P, Muangma N, Nanda S, Norum BE, Pan K, Parno D, Piasetzky E, Posik M, Punjabi V, Puckett AJR, Qian X, Qiang Y, Qiu X, Riordan S, Ron G, Saha A, Sawatzky B, Schiavilla R, Schoenrock B, Shabestari M, Shahinyan A, Širca S, Subedi R, Sulkosky V, Tobias WA, Tireman W, Urciuoli GM, Wang D, Wang K, Wang Y, Watson J, Wojtsekhowski B, Ye Z, Zhan X, Zhang Y, Zheng X, Zhao B, Zhu L. Measurement of the Target-Normal Single-Spin Asymmetry in Quasielastic Scattering from the Reaction (3)He(↑)(e,e'). Phys Rev Lett 2015; 115:172502. [PMID: 26551107 DOI: 10.1103/physrevlett.115.172502] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/05/2015] [Indexed: 06/05/2023]
Abstract
We report the first measurement of the target single-spin asymmetry, A(y), in quasielastic scattering from the inclusive reaction (3)He(↑)(e,e') on a (3)He gas target polarized normal to the lepton scattering plane. Assuming time-reversal invariance, this asymmetry is strictly zero for one-photon exchange. A nonzero A(y) can arise from the interference between the one- and two-photon exchange processes which is sensitive to the details of the substructure of the nucleon. An experiment recently completed at Jefferson Lab yielded asymmetries with high statistical precision at Q(2)=0.13, 0.46, and 0.97 GeV(2). These measurements demonstrate, for the first time, that the (3)He asymmetry is clearly nonzero and negative at the 4σ-9σ level. Using measured proton-to-(3)He cross-section ratios and the effective polarization approximation, neutron asymmetries of -(1-3)% were obtained. The neutron asymmetry at high Q(2) is related to moments of the generalized parton distributions (GPDs). Our measured neutron asymmetry at Q(2)=0.97 GeV(2) agrees well with a prediction based on two-photon exchange using a GPD model and thus provides a new, independent constraint on these distributions.
Collapse
Affiliation(s)
- Y-W Zhang
- Rutgers University, New Brunswick, New Jersey 08901, USA
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - E Long
- Kent State University, Kent, Ohio 44242, USA
| | | | - G Jin
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - K Allada
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Anderson
- Kent State University, Kent, Ohio 44242, USA
| | - J R M Annand
- Glasgow University, Glasgow G12 8QQ Scotland, United Kingdom
| | - T Averett
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - C Ayerbe-Gayoso
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - W Boeglin
- Florida International University, Miami, Florida 33181, USA
| | - P Bradshaw
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - A Camsonne
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Canan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - G D Cates
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - C Chen
- Hampton University, Hampton, Virginia 23669, USA
| | - J P Chen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Chudakov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R De Leo
- Università degli studi di Bari Aldo Moro, I-70121 Bari, Italy
| | - X Deng
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Dutta
- University of Kentucky, Lexington, Kentucky 40506, USA
| | - L El Fassi
- Rutgers University, New Brunswick, New Jersey 08901, USA
| | - D Flay
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Frullani
- Istituto Nazionale Di Fisica Nucleare, INFN/Sanita, 00161 Roma, Italy
| | - F Garibaldi
- Istituto Nazionale Di Fisica Nucleare, INFN/Sanita, 00161 Roma, Italy
| | - H Gao
- Duke University, Durham, North Carolina 27708, USA
| | - S Gilad
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - R Gilman
- Rutgers University, New Brunswick, New Jersey 08901, USA
| | - O Glamazdin
- Kharkov Institute of Physics and Technology, Kharkov 61108, Ukraine
| | - S Golge
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J Gomez
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - O Hansen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D W Higinbotham
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - T Holmstrom
- Longwood University, Farmville, Virginia 23909, USA
| | - J Huang
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - H Ibrahim
- Cairo University, Cairo, Giza 12613, Egypt
| | - C W de Jager
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Jensen
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - X Jiang
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - J St John
- Longwood University, Farmville, Virginia 23909, USA
| | - M Jones
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - H Kang
- Seoul National University, Seoul 151-742, Korea
| | - J Katich
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - H P Khanal
- Florida International University, Miami, Florida 33181, USA
| | - P King
- Ohio University, Athens, Ohio 45701, USA
| | - W Korsch
- University of Kentucky, Lexington, Kentucky 40506, USA
| | - J LeRose
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Lindgren
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - H-J Lu
- Huangshan University, Tunxi, Huangshan City, Anhui Province 245041, People's Republic of China
| | - W Luo
- Lanzhou University, Lanzhou, Gansu 730000, People's Republic of China
| | - P Markowitz
- Florida International University, Miami, Florida 33181, USA
| | - M Meziane
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - R Michaels
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Moffit
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Monaghan
- Hampton University, Hampton, Virginia 23669, USA
| | - N Muangma
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Nanda
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B E Norum
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - K Pan
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - D Parno
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | | | - M Posik
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - V Punjabi
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A J R Puckett
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - X Qian
- Duke University, Durham, North Carolina 27708, USA
| | - Y Qiang
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - X Qiu
- Lanzhou University, Lanzhou, Gansu 730000, People's Republic of China
| | - S Riordan
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - G Ron
- Hebrew University of Jerusalem, Jerusalem 91904, Israel
| | - A Saha
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Sawatzky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Schiavilla
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - B Schoenrock
- Northern Michigan University, Marquette, Michigan 49855, USA
| | - M Shabestari
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - A Shahinyan
- Yerevan Physics Institute, Yerevan 375036, Armenia
| | - S Širca
- Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia
- University of Ljubljana, SI-1000 Ljubljana, Slovenia
| | - R Subedi
- George Washington University, Washington, D.C. 20052, USA
| | - V Sulkosky
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - W A Tobias
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - W Tireman
- Northern Michigan University, Marquette, Michigan 49855, USA
| | - G M Urciuoli
- Istituto Nazionale Di Fisica Nucleare, INFN/Sanita, 00161 Roma, Italy
| | - D Wang
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - K Wang
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - Y Wang
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - J Watson
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Wojtsekhowski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Z Ye
- Hampton University, Hampton, Virginia 23669, USA
| | - X Zhan
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - Y Zhang
- Lanzhou University, Lanzhou, Gansu 730000, People's Republic of China
| | - X Zheng
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - B Zhao
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - L Zhu
- Hampton University, Hampton, Virginia 23669, USA
| |
Collapse
|
44
|
Chittenden R, Annand M, King P, Russell G. The Effect of Half Plunging and No Plunging as Alternative Winemaking Techniques on Phenolic Extraction and Pigment Composition of Wine. S AFR J ENOL VITIC 2015. [DOI: 10.21548/36-1-946] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
45
|
Angibaud PR, Obringer M, Marin J, Jeanty M, Esser N, Gilissen R, King P, Meerpoel L, Querolle O, Rees DC, Roux B, Saxty G, Verhulst T, Wroblowski B, Murray CC, Vialard J. Abstract 3641: Identification of naphthyridines as potent inhibitors of fibroblast growth factor receptor kinase family. Cancer Res 2015. [DOI: 10.1158/1538-7445.am2015-3641] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
The fibroblast growth factor receptor (FGFR) tyrosine kinase family members, FGFR1, 2, 3 and 4, have roles in a variety of key cellular processes, including proliferation, migration, survival, and differentiation1. Aberrant activation of FGFRs through mutation, amplification, chromosomal translocation, and ligand up-regulation being strongly implicated in oncogenic signalling in many tumour types, has triggered efforts to identify selective FGFR inhibitors. As a result, several potent FGFR kinase inhibitors are currently being evaluated in clinical studies across many tumor types, including non-small cell lung, breast and bladder cancers.
We have designed novel 1,5 and 1,7-naphthyridine derivatives that are potent kinase inhibitors of all FGFR family members in enzymatic and cellular systems. Initial hits were further optimized to increase potency and ADME properties leading to identification of a novel 1,5-naphthyridine-based chemical series with nanomolar affinity for FGFR1, 2, 3, and 4, activity in cells, and selectivity with respect to VEGFR-2. In vivo screening using an FGFR3-driven xenograft model revealed efficacious compounds that could be explored further as antitumoral agents.
This report represents the first disclosure of the structure-activity relationship and synthesis pathway of novel naphthyridine chemical series displaying nanomolar affinity for FGFRs1, 2, 3 and 4.
1 Dieci M. V., Ardenos M., Andre F., Soria J.C. Cancer Discovery. 2013, 3(3) 264-279.
Citation Format: Patrick R. Angibaud, Michel Obringer, Julien Marin, Matthieu Jeanty, Norbert Esser, Ron Gilissen, Peter King, Lieven Meerpoel, Olivier Querolle, David C. Rees, Bruno Roux, Gordon Saxty, Tinne Verhulst, Berthold Wroblowski, Christopher C. Murray, Jorge Vialard. Identification of naphthyridines as potent inhibitors of fibroblast growth factor receptor kinase family. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 3641. doi:10.1158/1538-7445.AM2015-3641
Collapse
Affiliation(s)
| | | | | | | | | | | | - Peter King
- 4Janssen Pharmaceutica NV, Beerse, Belgium
| | | | | | | | - Bruno Roux
- 1Janssen Research & Development, Val de Reuil, France
| | - Gordon Saxty
- 5Astex Pharmaceuticals, Cambridge, United Kingdom
| | | | | | | | | |
Collapse
|
46
|
King P, Ward R. Rethinking the Bloody Code in Eighteenth-Century Britain: Capital Punishment at the Centre and on the Periphery. Past Present 2015; 228:159-205. [PMID: 29780182 PMCID: PMC5955207 DOI: 10.1093/pastj/gtv026] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
During the long eighteenth century the capital code, and more specifically the so-called 'Bloody Code' which subjected a vast and increasing range of property crimes to the death penalty, was the centre of much popular attention and of extensive debate. The impact of the Bloody Code has also attracted much attention from historians, some of whom have argued that it played a vital role both within the criminal law and in eighteenth-century social relations more generally. However, the geography of the Bloody Code and the possibility that there were major regional differences both in the use of hanging, and in attitudes to it, has been largely ignored by historians. By systematically exploring the spatial dimensions of capital punishment in eighteenth-century Britain, this article demonstrates the refusal of many areas on the periphery to implement the Bloody Code. The reluctance in the far western and northern periphery of Britain to execute property offenders, it is argued, requires us to rethink some of our core assumptions about the key role historians have given to the Bloody Code in maintaining the hegemony of the elite, about the process by which the capital code came to be reformed, and about the reach of the state in the long eighteenth century.
Collapse
|
47
|
Affiliation(s)
- A Lewis
- SA Dental Service and School of Nursing; The University of Adelaide; South Australia Australia
| | - J Wallace
- School of Health Sciences; Faculty of Health and Medicine; The University of Newcastle; Ourimbah New South Wales Australia
| | - A Deutsch
- Private Practice; Bondi Junction Sydney New South Wales Australia
| | - P King
- Hunter New England Health and School of Health Sciences; Faculty of Health and Medicine; The University of Newcastle; Ourimbah New South Wales Australia
| |
Collapse
|
48
|
King P, Galvin R, O’Sullivan, Bennett Z. A systematic review of clinical prediction rules to aid treatment selection in musculoskeletal physiotherapy practice. BMC Proc 2015. [PMCID: PMC4306025 DOI: 10.1186/1753-6561-9-s1-a25] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
49
|
Mihovilovič M, Jin G, Long E, Zhang YW, Allada K, Anderson B, Annand JRM, Averett T, Boeglin W, Bradshaw P, Camsonne A, Canan M, Cates GD, Chen C, Chen JP, Chudakov E, De Leo R, Deng X, Deltuva A, Deur A, Dutta C, El Fassi L, Flay D, Frullani S, Garibaldi F, Gao H, Gilad S, Gilman R, Glamazdin O, Golak J, Golge S, Gomez J, Hansen O, Higinbotham DW, Holmstrom T, Huang J, Ibrahim H, de Jager CW, Jensen E, Jiang X, Jones M, Kang H, Katich J, Khanal HP, Kievsky A, King P, Korsch W, LeRose J, Lindgren R, Lu HJ, Luo W, Marcucci LE, Markowitz P, Meziane M, Michaels R, Moffit B, Monaghan P, Muangma N, Nanda S, Norum BE, Pan K, Parno D, Piasetzky E, Posik M, Punjabi V, Puckett AJR, Qian X, Qiang Y, Qui X, Riordan S, Saha A, Sauer PU, Sawatzky B, Schiavilla R, Schoenrock B, Shabestari M, Shahinyan A, Širca S, Skibiński R, John JS, Subedi R, Sulkosky V, Tobias WA, Tireman W, Urciuoli GM, Viviani M, Wang D, Wang K, Wang Y, Watson J, Wojtsekhowski B, Witała H, Ye Z, Zhan X, Zhang Y, Zheng X, Zhao B, Zhu L. Measurement of double-polarization asymmetries in the quasielastic (3)He[→](e[→],e(')d) process. Phys Rev Lett 2014; 113:232505. [PMID: 25526124 DOI: 10.1103/physrevlett.113.232505] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/11/2014] [Indexed: 06/04/2023]
Abstract
We present a precise measurement of double-polarization asymmetries in the ^{3}He[over →](e[over →],e^{'}d) reaction. This particular process is a uniquely sensitive probe of hadron dynamics in ^{3}He and the structure of the underlying electromagnetic currents. The measurements have been performed in and around quasielastic kinematics at Q^{2}=0.25(GeV/c)^{2} for missing momenta up to 270 MeV/c. The asymmetries are in fair agreement with the state-of-the-art calculations in terms of their functional dependencies on p_{m} and ω, but are systematically offset. Beyond the region of the quasielastic peak, the discrepancies become even more pronounced. Thus, our measurements have been able to reveal deficiencies in the most sophisticated calculations of the three-body nuclear system, and indicate that further refinement in the treatment of their two-and/or three-body dynamics is required.
Collapse
Affiliation(s)
| | - G Jin
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - E Long
- Kent State University, Kent, Ohio 44242, USA
| | - Y-W Zhang
- Rutgers University, New Brunswick, New Jersey 08901, USA
| | - K Allada
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Anderson
- Kent State University, Kent, Ohio 44242, USA
| | - J R M Annand
- Glasgow University, Glasgow G12 8QQ, Scotland, United Kingdom
| | - T Averett
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - W Boeglin
- Florida International University, Miami, Florida 33181, USA
| | - P Bradshaw
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - A Camsonne
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Canan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - G D Cates
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - C Chen
- Hampton University, Hampton, Virginia 23669, USA
| | - J P Chen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Chudakov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R De Leo
- Università degli studi di Bari Aldo Moro, I-70121 Bari, Italy
| | - X Deng
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - A Deltuva
- Center for Nuclear Physics, University of Lisbon, P-1649-003 Lisbon, Portugal and Institute for Theoretical Physics and Astronomy, Vilnius University, LT-01108 Vilnius, Lithuania
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Dutta
- University of Kentucky, Lexington, Kentucky 40506, USA
| | - L El Fassi
- Rutgers University, New Brunswick, New Jersey 08901, USA
| | - D Flay
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Frullani
- Istituto Nazionale Di Fisica Nucleare, INFN/Sanita, Roma, Italy
| | - F Garibaldi
- Istituto Nazionale Di Fisica Nucleare, INFN/Sanita, Roma, Italy
| | - H Gao
- Duke University, Durham, North Carolina 27708, USA
| | - S Gilad
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - R Gilman
- Rutgers University, New Brunswick, New Jersey 08901, USA
| | - O Glamazdin
- Kharkov Institute of Physics and Technology, Kharkov 61108, Ukraine
| | - J Golak
- M. Smoluchowski Institute of Physics, Jagiellonian University, PL-30059 Kraków, Poland
| | - S Golge
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J Gomez
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - O Hansen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D W Higinbotham
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - T Holmstrom
- Longwood College, Farmville, Virginia 23909, USA
| | - J Huang
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - H Ibrahim
- Cairo University, Cairo, Giza 12613, Egypt
| | - C W de Jager
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Jensen
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - X Jiang
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - M Jones
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - H Kang
- Seoul National University, Seoul, Korea
| | - J Katich
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - H P Khanal
- Florida International University, Miami, Florida 33181, USA
| | | | - P King
- Ohio University, Athens, Ohio 45701, USA
| | - W Korsch
- University of Kentucky, Lexington, Kentucky 40506, USA
| | - J LeRose
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Lindgren
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - H-J Lu
- Huangshan University, People's Republic of China
| | - W Luo
- Lanzhou University, Lanzhou, Gansu, 730000, People's Republic of China
| | - L E Marcucci
- Physics Department, Pisa University, I-56127 Pisa, Italy
| | - P Markowitz
- Florida International University, Miami, Florida 33181, USA
| | - M Meziane
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - R Michaels
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Moffit
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Monaghan
- Hampton University, Hampton, Virginia 23669, USA
| | - N Muangma
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Nanda
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B E Norum
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - K Pan
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - D Parno
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | | | - M Posik
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - V Punjabi
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A J R Puckett
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - X Qian
- Duke University, Durham, North Carolina 27708, USA
| | - Y Qiang
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - X Qui
- Lanzhou University, Lanzhou, Gansu, 730000, People's Republic of China
| | - S Riordan
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - A Saha
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P U Sauer
- Institute for Theoretical Physics, University of Hannover, D-30167 Hannover, Germany
| | - B Sawatzky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Schiavilla
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA and Old Dominion University, Norfolk, Virginia 23529, USA
| | - B Schoenrock
- Northern Michigan University, Marquette, Michigan 49855, USA
| | - M Shabestari
- University of Virginia, Charlottesville, Virginia 22908, USA
| | | | - S Širca
- Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia and University of Ljubljana, SI-1000 Ljubljana, Slovenia
| | - R Skibiński
- M. Smoluchowski Institute of Physics, Jagiellonian University, PL-30059 Kraków, Poland
| | - J St John
- Longwood College, Farmville, Virginia 23909, USA
| | - R Subedi
- George Washington University, Washington, D.C. 20052, USA
| | - V Sulkosky
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - W A Tobias
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - W Tireman
- Northern Michigan University, Marquette, Michigan 49855, USA
| | - G M Urciuoli
- Istituto Nazionale Di Fisica Nucleare, INFN/Sanita, Roma, Italy
| | | | - D Wang
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - K Wang
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - Y Wang
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - J Watson
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Wojtsekhowski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - H Witała
- M. Smoluchowski Institute of Physics, Jagiellonian University, PL-30059 Kraków, Poland
| | - Z Ye
- Hampton University, Hampton, Virginia 23669, USA
| | - X Zhan
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - Y Zhang
- Lanzhou University, Lanzhou, Gansu, 730000, People's Republic of China
| | - X Zheng
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - B Zhao
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - L Zhu
- Hampton University, Hampton, Virginia 23669, USA
| |
Collapse
|
50
|
Vidic S, Esser N, Hoogt RD, Verberne I, Kogan-Sakin I, Stein Y, Rotter V, Barbier M, Chong Y, Breucker SD, Smans K, Akerfelt M, Nees M, King P, Hickson I, Weerden WV, Graeser R. Abstract 2023: Complex in vitro and in vivo prostate cancer models for the PREDECT consortium. Cancer Res 2014. [DOI: 10.1158/1538-7445.am2014-2023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
The failure of many drugs in the clinic - drugs proven to be active in pre-clinical assays - has raised question marks on the predictive power of these models, often based on cell line data. The divergence of these cell lines from the original tumors, and their rapid growth as simple monocultures on 2D plastic were highlighted as potentially causing these issues. Implantation of the cell lines into mice adds complexity to these models, but the crosstalk with mouse stroma also leads to confounding results (eg, HGF, IL-6).
PREDECT, a European consortium funded by the Innovative Medicines Initiative (IMI), has the goal to build and characterise more predictive Oncology model platforms for three pathologies (lung, breast and prostate). Signalling pathways and heterogeneity of these model platforms are compared to each other as well as to primary human tissue using a central TMA-based platform.
For prostate cancer, a 3D tumor growth assay system was established recently using RFP/FLuc-labelled LNCaP, PC346C, or VCaP human prostate cancer cells grown in a matrix of Matrigel, collagen, or a mix of the two, in the presence or absence of GFP/RLuc labelled human stromal cells (WPMY, or an immortalised cancer-associated fibroblast cell line, CAF). Cell densities, ratios, and matrix concentrations/volumes were optimised for cells cultured for 3 weeks. In an approach to improve tumor-stroma crosstalk in vivo, LNCaP cells pre-grown in 3D cultures with or without human stromal cells were implanted orthotopically into SCID mice. Growth of the tumor and stromal cells was monitored by in vivo bioluminescence, and the effect of the co-implantation on the primary tumor and metastasis was analysed via ex-vivo luciferase assays and IHC.
Whereas LNCaP and PC346C cells readily formed spheroids in 3D culture, VCaPs remained as single cells. Growth of VCaPs was facilitated by pre-forming spheroids in vitro, followed by matrix embedding. Addition of stromal cells stimulated growth of not only the tumor, but also the stromal cells in some conditions, as monitored using RFP and GFP live cell imaging. 3D, as well as stromal cell-mediated treatment resistance was observed. Using the fluorescent dyes Hoechst, EdU, and NucView, the proliferative status of individual cells within spheroids could be analysed in situ. Finally, paraffin-embedding of the 3D cultures allowed for TMA analysis and comparison to other models and patient samples.Results will also be shown on the orthotopic growth of LNCaP tumors and the effect of stromal cell co-implantation.
Introducing complexity to cell culture may help to generate more realistic, and thus also more predictive models - in a first step using even standard cell lines.
Citation Format: Suzana Vidic, Norbert Esser, Ronald de Hoogt, Ingrid Verberne, Ira Kogan-Sakin, Yan Stein, Varda Rotter, Michael Barbier, Yolanda Chong, Sabine De Breucker, Karine Smans, Malin Akerfelt, Matthias Nees, Peter King, Ian Hickson, Wytske van Weerden, Ralph Graeser. Complex in vitro and in vivo prostate cancer models for the PREDECT consortium. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 2023. doi:10.1158/1538-7445.AM2014-2023
Collapse
Affiliation(s)
| | | | | | | | | | - Yan Stein
- 3Weizmann Institute, Rehovot, Israel
| | | | | | | | | | | | | | | | - Peter King
- 5Janssen Pharmaceutica INC, Springhouse, PA
| | | | | | | |
Collapse
|